Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-127-3p PPARG -0.63 0.04008 0.8 0.14249 miRanda -0.27 0.00145 NA
2 hsa-miR-130a-3p PPARG 2.02 0 0.8 0.14249 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.21 0.01438 NA
3 hsa-miR-142-3p PPARG 2.75 0 0.8 0.14249 miRanda -0.29 1.0E-5 NA
4 hsa-miR-27a-3p PPARG 1.67 0 0.8 0.14249 MirTarget; miRNATAP -0.61 0 NA
5 hsa-miR-338-5p PPARG -0.58 0.04722 0.8 0.14249 MirTarget; PITA; miRNATAP -0.42 0 NA
6 hsa-miR-34c-5p PPARG 2.07 0 0.8 0.14249 miRanda -0.32 1.0E-5 NA
7 hsa-miR-455-5p PPARG 2.26 0 0.8 0.14249 miRanda -0.29 0.00047 NA
8 hsa-miR-511-5p PPARG 1.04 0.00234 0.8 0.14249 MirTarget -0.34 1.0E-5 NA
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 171 1496 1.655e-69 7.702e-66
2 POSITIVE REGULATION OF RESPONSE TO STIMULUS 187 1929 4.398e-65 1.023e-61
3 REGULATION OF CELL DEATH 161 1472 3.709e-62 5.752e-59
4 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 176 1848 1.823e-59 2.121e-56
5 IMMUNE SYSTEM PROCESS 180 1984 8.89e-58 8.273e-55
6 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 151 1395 3.037e-57 2.355e-54
7 POSITIVE REGULATION OF GENE EXPRESSION 164 1733 1.928e-54 1.282e-51
8 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 167 1805 3.519e-54 2.047e-51
9 RESPONSE TO OXYGEN CONTAINING COMPOUND 146 1381 7.934e-54 4.102e-51
10 RESPONSE TO ENDOGENOUS STIMULUS 148 1450 1.137e-52 5.289e-50
11 NEGATIVE REGULATION OF CELL DEATH 115 872 2.042e-51 8.636e-49
12 LOCOMOTION 126 1114 4.547e-49 1.763e-46
13 RESPONSE TO EXTERNAL STIMULUS 160 1821 1.412e-48 5.054e-46
14 REGULATION OF CELL DIFFERENTIATION 144 1492 4.389e-48 1.459e-45
15 RESPONSE TO LIPID 110 888 2.473e-46 7.672e-44
16 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 150 1672 2.72e-46 7.911e-44
17 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 122 1142 9.639e-45 2.638e-42
18 POSITIVE REGULATION OF CELL COMMUNICATION 141 1532 1.613e-44 4.169e-42
19 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 127 1275 2.194e-43 5.372e-41
20 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 101 799 3.586e-43 8.344e-41
21 REGULATION OF RESPONSE TO STRESS 136 1468 4.145e-43 9.183e-41
22 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 150 1784 8.416e-43 1.78e-40
23 RESPONSE TO ORGANIC CYCLIC COMPOUND 107 917 1.611e-42 3.26e-40
24 REGULATION OF IMMUNE SYSTEM PROCESS 132 1403 1.82e-42 3.529e-40
25 POSITIVE REGULATION OF CELL PROLIFERATION 101 814 1.955e-42 3.639e-40
26 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 136 1492 2.619e-42 4.687e-40
27 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 104 876 5.772e-42 9.946e-40
28 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 143 1656 6.255e-42 1.039e-39
29 REGULATION OF PHOSPHORUS METABOLIC PROCESS 141 1618 9.692e-42 1.555e-39
30 CELL MOTILITY 101 835 1.967e-41 2.952e-39
31 LOCALIZATION OF CELL 101 835 1.967e-41 2.952e-39
32 TISSUE DEVELOPMENT 135 1518 9.086e-41 1.321e-38
33 REGULATION OF CELLULAR COMPONENT MOVEMENT 96 771 2.181e-40 3.075e-38
34 REGULATION OF PROTEIN MODIFICATION PROCESS 143 1710 2.652e-40 3.63e-38
35 POSITIVE REGULATION OF LOCOMOTION 72 420 1.867e-39 2.482e-37
36 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 105 983 3.694e-38 4.775e-36
37 POSITIVE REGULATION OF MOLECULAR FUNCTION 143 1791 5.457e-38 6.862e-36
38 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 107 1036 1.411e-37 1.683e-35
39 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 107 1036 1.411e-37 1.683e-35
40 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 105 1004 2.497e-37 2.905e-35
41 POSITIVE REGULATION OF CELL DIFFERENTIATION 95 823 3.583e-37 4.066e-35
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 122 1360 6.678e-37 7.399e-35
43 IMMUNE SYSTEM DEVELOPMENT 80 582 1.245e-36 1.347e-34
44 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 104 1008 1.965e-36 2.077e-34
45 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 109 1135 2.115e-35 2.187e-33
46 IMMUNE RESPONSE 107 1100 3.237e-35 3.275e-33
47 REGULATION OF CELL ADHESION 81 629 5.272e-35 5.219e-33
48 DEFENSE RESPONSE 113 1231 6.226e-35 6.035e-33
49 CELL ACTIVATION 77 568 8.101e-35 7.693e-33
50 RESPONSE TO ABIOTIC STIMULUS 102 1024 2.222e-34 2.068e-32
51 NEGATIVE REGULATION OF CELL PROLIFERATION 81 643 2.626e-34 2.395e-32
52 RESPONSE TO HORMONE 95 893 3.043e-34 2.723e-32
53 CARDIOVASCULAR SYSTEM DEVELOPMENT 88 788 2.956e-33 2.547e-31
54 CIRCULATORY SYSTEM DEVELOPMENT 88 788 2.956e-33 2.547e-31
55 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 92 867 4.827e-33 4.084e-31
56 NEGATIVE REGULATION OF CELL COMMUNICATION 108 1192 8.464e-33 7.033e-31
57 INFLAMMATORY RESPONSE 67 454 1.434e-32 1.17e-30
58 RESPONSE TO WOUNDING 74 563 1.503e-32 1.206e-30
59 CELL DEATH 98 1001 2.318e-32 1.828e-30
60 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 57 321 3.996e-32 3.099e-30
61 RESPONSE TO CYTOKINE 82 714 8.094e-32 6.174e-30
62 NEGATIVE REGULATION OF GENE EXPRESSION 120 1493 1.211e-31 9.086e-30
63 REGULATION OF CYTOKINE PRODUCTION 72 563 6.779e-31 5.007e-29
64 POSITIVE REGULATION OF CELL DEATH 74 605 1.783e-30 1.296e-28
65 REGULATION OF TRANSPORT 131 1804 2.656e-30 1.901e-28
66 RESPONSE TO BIOTIC STIMULUS 89 886 3.858e-30 2.72e-28
67 WOUND HEALING 65 470 6.549e-30 4.548e-28
68 POSITIVE REGULATION OF CATALYTIC ACTIVITY 118 1518 9.687e-30 6.532e-28
69 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 84 801 9.596e-30 6.532e-28
70 RESPONSE TO NITROGEN COMPOUND 87 859 1.037e-29 6.896e-28
71 ORGAN MORPHOGENESIS 86 841 1.15e-29 7.535e-28
72 LEUKOCYTE ACTIVATION 61 414 1.219e-29 7.881e-28
73 LEUKOCYTE DIFFERENTIATION 52 292 2.01e-29 1.281e-27
74 LEUKOCYTE MIGRATION 49 259 4.964e-29 3.121e-27
75 VASCULATURE DEVELOPMENT 63 469 2.838e-28 1.761e-26
76 CELLULAR RESPONSE TO LIPID 62 457 4.495e-28 2.752e-26
77 LYMPHOCYTE ACTIVATION 54 342 8.018e-28 4.845e-26
78 RESPONSE TO BACTERIUM 66 528 9.515e-28 5.676e-26
79 RESPONSE TO STEROID HORMONE 64 497 1.176e-27 6.924e-26
80 EXTRACELLULAR STRUCTURE ORGANIZATION 51 304 1.357e-27 7.89e-26
81 EPITHELIUM DEVELOPMENT 88 945 2.164e-27 1.243e-25
82 REGULATION OF MAPK CASCADE 73 660 2.841e-27 1.612e-25
83 INTRACELLULAR SIGNAL TRANSDUCTION 116 1572 3.423e-27 1.919e-25
84 REGULATION OF CELL DEVELOPMENT 82 836 5.035e-27 2.789e-25
85 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 86 926 1.122e-26 6.14e-25
86 BIOLOGICAL ADHESION 91 1032 1.356e-26 7.336e-25
87 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 90 1021 2.761e-26 1.477e-24
88 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 112 1517 3.221e-26 1.692e-24
89 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 96 1152 3.236e-26 1.692e-24
90 REGULATION OF KINASE ACTIVITY 77 776 1.087e-25 5.622e-24
91 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 75 740 1.339e-25 6.847e-24
92 SINGLE ORGANISM CELL ADHESION 59 459 1.723e-25 8.716e-24
93 POSITIVE REGULATION OF TRANSPORT 84 936 4.93e-25 2.467e-23
94 REGULATION OF PEPTIDASE ACTIVITY 54 392 7.504e-25 3.714e-23
95 RESPONSE TO ALCOHOL 52 362 7.974e-25 3.905e-23
96 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 41 213 9.611e-25 4.659e-23
97 RESPONSE TO GROWTH FACTOR 59 475 1.045e-24 5.013e-23
98 REGULATION OF HYDROLASE ACTIVITY 101 1327 1.526e-24 7.247e-23
99 LEUKOCYTE CELL CELL ADHESION 44 255 1.929e-24 9.067e-23
100 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 58 465 2.16e-24 1.005e-22
101 TISSUE MORPHOGENESIS 62 533 2.203e-24 1.015e-22
102 BLOOD VESSEL MORPHOGENESIS 51 364 7.433e-24 3.391e-22
103 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 35 154 7.896e-24 3.567e-22
104 REGULATION OF CELL CELL ADHESION 52 380 8.036e-24 3.595e-22
105 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 89 1087 9.938e-24 4.404e-22
106 CELLULAR RESPONSE TO CYTOKINE STIMULUS 65 606 1.433e-23 6.291e-22
107 REGULATION OF DEFENSE RESPONSE 73 759 1.533e-23 6.666e-22
108 REGULATION OF TRANSFERASE ACTIVITY 82 946 1.92e-23 8.273e-22
109 CELL DEVELOPMENT 103 1426 2.774e-23 1.184e-21
110 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 69 689 2.882e-23 1.219e-21
111 HOMEOSTATIC PROCESS 99 1337 3.8e-23 1.593e-21
112 RESPONSE TO INORGANIC SUBSTANCE 57 479 5.905e-23 2.453e-21
113 CELLULAR RESPONSE TO BIOTIC STIMULUS 35 163 6.027e-23 2.482e-21
114 REGULATION OF RESPONSE TO WOUNDING 53 413 6.234e-23 2.545e-21
115 REGULATION OF CELLULAR LOCALIZATION 96 1277 6.69e-23 2.707e-21
116 AGING 43 264 7.069e-23 2.836e-21
117 PROTEIN PHOSPHORYLATION 81 944 7.138e-23 2.839e-21
118 TAXIS 56 464 7.26e-23 2.863e-21
119 MORPHOGENESIS OF AN EPITHELIUM 52 400 8.939e-23 3.495e-21
120 REGULATION OF CELL ACTIVATION 57 484 9.907e-23 3.818e-21
121 NEUROGENESIS 101 1402 9.93e-23 3.818e-21
122 REGULATION OF PROTEIN LOCALIZATION 81 950 1.071e-22 4.084e-21
123 REGULATION OF GROWTH 65 633 1.568e-22 5.932e-21
124 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 81 957 1.711e-22 6.421e-21
125 PHOSPHORYLATION 93 1228 2.148e-22 7.996e-21
126 POSITIVE REGULATION OF CELL ADHESION 50 376 2.257e-22 8.333e-21
127 NEGATIVE REGULATION OF CELL DIFFERENTIATION 63 609 5.057e-22 1.853e-20
128 CELLULAR RESPONSE TO NITROGEN COMPOUND 57 505 8.087e-22 2.94e-20
129 REGULATION OF PROTEOLYSIS 68 711 8.214e-22 2.963e-20
130 REGULATION OF IMMUNE RESPONSE 75 858 1.157e-21 4.141e-20
131 GLAND DEVELOPMENT 50 395 2.052e-21 7.29e-20
132 RESPONSE TO DRUG 52 431 2.799e-21 9.866e-20
133 LYMPHOCYTE DIFFERENTIATION 37 209 4.066e-21 1.423e-19
134 POSITIVE REGULATION OF MAPK CASCADE 54 470 4.552e-21 1.581e-19
135 POSITIVE REGULATION OF CYTOKINE PRODUCTION 48 370 4.75e-21 1.637e-19
136 CELL CELL ADHESION 61 608 1.155e-20 3.95e-19
137 TUBE DEVELOPMENT 58 552 1.185e-20 4.024e-19
138 REGULATION OF APOPTOTIC SIGNALING PATHWAY 47 363 1.354e-20 4.566e-19
139 POSITIVE REGULATION OF KINASE ACTIVITY 54 482 1.472e-20 4.928e-19
140 CELLULAR RESPONSE TO STRESS 103 1565 2.945e-20 9.789e-19
141 REGULATION OF HOMOTYPIC CELL CELL ADHESION 43 307 2.981e-20 9.838e-19
142 SKELETAL SYSTEM DEVELOPMENT 52 455 3.254e-20 1.066e-18
143 REPRODUCTION 92 1297 3.341e-20 1.087e-18
144 REGULATION OF EPITHELIAL CELL PROLIFERATION 41 285 8.548e-20 2.762e-18
145 INNATE IMMUNE RESPONSE 60 619 1.355e-19 4.348e-18
146 RESPONSE TO OXYGEN LEVELS 42 311 3.355e-19 1.069e-17
147 HEART DEVELOPMENT 51 466 5.095e-19 1.613e-17
148 REGULATION OF CYTOKINE SECRETION 30 149 5.396e-19 1.697e-17
149 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 51 470 7.381e-19 2.305e-17
150 EMBRYO DEVELOPMENT 72 894 8.311e-19 2.578e-17
151 REGULATION OF OSSIFICATION 32 178 1.252e-18 3.859e-17
152 REGULATION OF CELLULAR RESPONSE TO STRESS 62 691 1.525e-18 4.668e-17
153 REGULATION OF CELL CYCLE 74 949 1.58e-18 4.805e-17
154 POSITIVE REGULATION OF HYDROLASE ACTIVITY 72 905 1.63e-18 4.926e-17
155 ANGIOGENESIS 40 293 1.655e-18 4.967e-17
156 CELL PROLIFERATION 61 672 1.681e-18 5.015e-17
157 REPRODUCTIVE SYSTEM DEVELOPMENT 47 408 1.696e-18 5.026e-17
158 POSITIVE REGULATION OF CELL ACTIVATION 41 311 2.208e-18 6.501e-17
159 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 58 616 2.283e-18 6.681e-17
160 OSSIFICATION 37 251 2.478e-18 7.206e-17
161 ZYMOGEN ACTIVATION 26 112 2.918e-18 8.434e-17
162 RESPONSE TO MECHANICAL STIMULUS 34 210 3.095e-18 8.889e-17
163 NEGATIVE REGULATION OF MOLECULAR FUNCTION 79 1079 3.815e-18 1.089e-16
164 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 114 1977 5.219e-18 1.481e-16
165 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 46 404 6.351e-18 1.791e-16
166 CELLULAR RESPONSE TO HORMONE STIMULUS 54 552 6.908e-18 1.936e-16
167 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 24 95 7.099e-18 1.978e-16
168 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 51 498 8.835e-18 2.447e-16
169 REGULATION OF SECRETION 61 699 1.136e-17 3.127e-16
170 CHEMICAL HOMEOSTASIS 69 874 1.383e-17 3.787e-16
171 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 39 296 1.57e-17 4.246e-16
172 MORPHOGENESIS OF A BRANCHING STRUCTURE 30 167 1.566e-17 4.246e-16
173 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 56 602 1.597e-17 4.297e-16
174 POSITIVE REGULATION OF PROTEOLYSIS 43 363 1.842e-17 4.926e-16
175 REGULATION OF NEURON DEATH 36 252 2.041e-17 5.426e-16
176 RESPONSE TO METAL ION 41 333 2.664e-17 7.044e-16
177 REGULATION OF MAP KINASE ACTIVITY 40 319 3.475e-17 9.134e-16
178 T CELL DIFFERENTIATION 26 123 3.509e-17 9.172e-16
179 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 33 213 3.851e-17 1.001e-15
180 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 62 750 8.224e-17 2.126e-15
181 REGULATION OF BODY FLUID LEVELS 50 506 8.304e-17 2.135e-15
182 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 28 152 9.604e-17 2.455e-15
183 REGULATION OF HEMOPOIESIS 39 314 1.216e-16 3.092e-15
184 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 46 437 1.369e-16 3.461e-15
185 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 50 514 1.58e-16 3.974e-15
186 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 26 131 1.81e-16 4.529e-15
187 RESPONSE TO OXIDATIVE STRESS 41 352 1.94e-16 4.828e-15
188 RESPONSE TO ACID CHEMICAL 39 319 2.091e-16 5.176e-15
189 REGULATION OF PROTEIN SECRETION 43 389 2.387e-16 5.878e-15
190 POSITIVE REGULATION OF CELL CELL ADHESION 34 243 3.104e-16 7.602e-15
191 REGULATION OF HOMEOSTATIC PROCESS 46 447 3.268e-16 7.96e-15
192 REGENERATION 28 161 4.576e-16 1.109e-14
193 REGULATION OF INFLAMMATORY RESPONSE 37 294 4.928e-16 1.188e-14
194 GLIOGENESIS 29 175 5.173e-16 1.241e-14
195 RESPONSE TO ESTROGEN 32 218 5.817e-16 1.388e-14
196 POSITIVE REGULATION OF DEFENSE RESPONSE 41 364 6.336e-16 1.504e-14
197 PROTEIN MATURATION 35 265 6.95e-16 1.642e-14
198 REGULATION OF NEURON DIFFERENTIATION 51 554 7.517e-16 1.767e-14
199 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 59 724 9.441e-16 2.207e-14
200 REGULATION OF CYTOPLASMIC TRANSPORT 47 481 1.14e-15 2.647e-14
201 REGULATION OF INTRACELLULAR TRANSPORT 54 621 1.144e-15 2.647e-14
202 POSITIVE REGULATION OF IMMUNE RESPONSE 51 563 1.45e-15 3.34e-14
203 TUBE MORPHOGENESIS 38 323 1.842e-15 4.221e-14
204 MUSCLE STRUCTURE DEVELOPMENT 44 432 2.176e-15 4.963e-14
205 POSITIVE REGULATION OF CHEMOTAXIS 24 120 2.215e-15 5.028e-14
206 CYTOKINE MEDIATED SIGNALING PATHWAY 45 452 2.398e-15 5.417e-14
207 RESPONSE TO PURINE CONTAINING COMPOUND 27 158 2.434e-15 5.47e-14
208 POSITIVE REGULATION OF CELL DEVELOPMENT 46 472 2.578e-15 5.768e-14
209 EPITHELIAL CELL DIFFERENTIATION 47 495 3.417e-15 7.608e-14
210 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 56 684 4.441e-15 9.841e-14
211 CELL CHEMOTAXIS 27 162 4.637e-15 1.018e-13
212 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 27 162 4.637e-15 1.018e-13
213 REGULATION OF LEUKOCYTE MIGRATION 26 149 4.786e-15 1.045e-13
214 RESPONSE TO CORTICOSTEROID 28 176 4.912e-15 1.068e-13
215 REGULATION OF NEURON APOPTOTIC PROCESS 29 192 6.472e-15 1.401e-13
216 REGULATION OF CHEMOTAXIS 28 180 8.865e-15 1.91e-13
217 REGULATION OF INNATE IMMUNE RESPONSE 39 357 9.229e-15 1.979e-13
218 CELLULAR HOMEOSTASIS 55 676 1.036e-14 2.212e-13
219 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 30 211 1.164e-14 2.474e-13
220 RESPONSE TO KETONE 28 182 1.184e-14 2.503e-13
221 CELL FATE COMMITMENT 31 227 1.295e-14 2.728e-13
222 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 47 513 1.319e-14 2.765e-13
223 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 52 616 1.341e-14 2.797e-13
224 PEPTIDYL AMINO ACID MODIFICATION 62 841 1.724e-14 3.581e-13
225 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 39 365 1.915e-14 3.961e-13
226 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 29 200 1.931e-14 3.976e-13
227 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 48 541 2.305e-14 4.705e-13
228 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 48 541 2.305e-14 4.705e-13
229 RESPONSE TO PEPTIDE 41 404 2.319e-14 4.713e-13
230 GLAND MORPHOGENESIS 21 97 2.386e-14 4.826e-13
231 CELLULAR RESPONSE TO EXTERNAL STIMULUS 33 264 2.411e-14 4.857e-13
232 RHYTHMIC PROCESS 35 298 2.598e-14 5.211e-13
233 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 22 109 2.697e-14 5.385e-13
234 REGULATION OF BINDING 34 283 3.148e-14 6.26e-13
235 CELLULAR RESPONSE TO ACID CHEMICAL 27 175 3.307e-14 6.548e-13
236 MESENCHYME DEVELOPMENT 28 190 3.618e-14 7.133e-13
237 REGULATION OF CELL MORPHOGENESIS 48 552 4.929e-14 9.677e-13
238 REGULATION OF ORGANELLE ORGANIZATION 75 1178 5.22e-14 1.02e-12
239 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 48 554 5.647e-14 1.099e-12
240 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 24 138 5.897e-14 1.143e-12
241 CONNECTIVE TISSUE DEVELOPMENT 28 194 6.187e-14 1.195e-12
242 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 25 153 7.76e-14 1.492e-12
243 NEGATIVE REGULATION OF PHOSPHORYLATION 41 422 1.007e-13 1.928e-12
244 MULTI MULTICELLULAR ORGANISM PROCESS 29 213 1.019e-13 1.944e-12
245 CELLULAR COMPONENT MORPHOGENESIS 63 900 1.099e-13 2.088e-12
246 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 23 129 1.142e-13 2.16e-12
247 ACTIVATION OF PROTEIN KINASE ACTIVITY 33 279 1.189e-13 2.24e-12
248 LEUKOCYTE CHEMOTAXIS 22 117 1.258e-13 2.36e-12
249 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 26 171 1.417e-13 2.648e-12
250 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 38 370 1.475e-13 2.745e-12
251 REGULATION OF SYSTEM PROCESS 45 507 1.546e-13 2.866e-12
252 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 24 144 1.567e-13 2.893e-12
253 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 33 282 1.614e-13 2.969e-12
254 REGULATION OF VASCULATURE DEVELOPMENT 30 233 1.702e-13 3.119e-12
255 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 29 218 1.868e-13 3.408e-12
256 REGULATION OF CELLULAR PROTEIN LOCALIZATION 47 552 1.989e-13 3.616e-12
257 NEGATIVE REGULATION OF CELL CYCLE 41 433 2.369e-13 4.29e-12
258 REGULATION OF LEUKOCYTE PROLIFERATION 28 206 2.855e-13 5.148e-12
259 POSITIVE REGULATION OF RESPONSE TO WOUNDING 25 162 2.973e-13 5.341e-12
260 POSITIVE REGULATION OF GROWTH 30 238 2.994e-13 5.359e-12
261 REGULATION OF DEVELOPMENTAL GROWTH 33 289 3.242e-13 5.757e-12
262 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 33 289 3.242e-13 5.757e-12
263 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 20 98 3.265e-13 5.777e-12
264 EMBRYONIC MORPHOGENESIS 46 539 3.356e-13 5.914e-12
265 POSITIVE REGULATION OF HEMOPOIESIS 25 163 3.431e-13 6.025e-12
266 MUSCLE TISSUE DEVELOPMENT 32 275 4.443e-13 7.771e-12
267 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 20 100 4.885e-13 8.513e-12
268 POSITIVE REGULATION OF PROTEIN SECRETION 28 211 5.222e-13 9.066e-12
269 REGULATION OF MUSCLE CELL DIFFERENTIATION 24 152 5.339e-13 9.236e-12
270 PROTEOLYSIS 74 1208 5.419e-13 9.339e-12
271 REGULATION OF PROTEIN IMPORT 26 183 7.194e-13 1.235e-11
272 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 21 115 8.308e-13 1.421e-11
273 REGULATION OF MUSCLE ORGAN DEVELOPMENT 20 103 8.775e-13 1.496e-11
274 SENSORY ORGAN DEVELOPMENT 43 493 9.961e-13 1.692e-11
275 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 35 337 1.007e-12 1.704e-11
276 RESPONSE TO RADIATION 39 413 1.016e-12 1.712e-11
277 NEURON DIFFERENTIATION 60 874 1.034e-12 1.737e-11
278 NEGATIVE REGULATION OF NEURON DEATH 25 171 1.04e-12 1.741e-11
279 POSITIVE REGULATION OF PROTEIN IMPORT 20 104 1.062e-12 1.771e-11
280 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 58 829 1.176e-12 1.955e-11
281 REGULATION OF FAT CELL DIFFERENTIATION 20 106 1.544e-12 2.556e-11
282 STEM CELL DIFFERENTIATION 26 190 1.746e-12 2.881e-11
283 REGULATION OF CELLULAR COMPONENT BIOGENESIS 55 767 1.803e-12 2.965e-11
284 NEGATIVE REGULATION OF CELL ADHESION 28 223 2.071e-12 3.392e-11
285 POSITIVE REGULATION OF CYTOKINE SECRETION 19 96 2.29e-12 3.739e-11
286 REGULATION OF PROTEIN KINASE B SIGNALING 21 121 2.333e-12 3.795e-11
287 IMMUNE EFFECTOR PROCESS 42 486 2.51e-12 4.069e-11
288 IN UTERO EMBRYONIC DEVELOPMENT 33 311 2.529e-12 4.071e-11
289 HEMOSTASIS 33 311 2.529e-12 4.071e-11
290 CENTRAL NERVOUS SYSTEM DEVELOPMENT 59 872 2.975e-12 4.774e-11
291 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 18 86 3.192e-12 5.104e-11
292 DEVELOPMENTAL GROWTH 34 333 3.472e-12 5.533e-11
293 GROWTH 38 410 3.551e-12 5.639e-11
294 HEART MORPHOGENESIS 27 212 3.678e-12 5.822e-11
295 COLLAGEN FIBRIL ORGANIZATION 13 38 3.716e-12 5.861e-11
296 PROTEIN COMPLEX SUBUNIT ORGANIZATION 84 1527 3.832e-12 6.024e-11
297 CELLULAR RESPONSE TO ABIOTIC STIMULUS 30 263 4.069e-12 6.374e-11
298 PLACENTA DEVELOPMENT 22 138 4.113e-12 6.422e-11
299 RESPONSE TO ORGANOPHOSPHORUS 22 139 4.775e-12 7.431e-11
300 REGULATION OF LEUKOCYTE DIFFERENTIATION 28 232 5.473e-12 8.488e-11
301 REGULATION OF DNA METABOLIC PROCESS 34 340 6.223e-12 9.62e-11
302 RESPONSE TO EXTRACELLULAR STIMULUS 39 441 7.788e-12 1.2e-10
303 REGULATION OF MUSCLE TISSUE DEVELOPMENT 19 103 8.528e-12 1.31e-10
304 REGULATION OF PROTEIN TARGETING 32 307 8.821e-12 1.35e-10
305 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 27 220 8.88e-12 1.355e-10
306 CELLULAR CHEMICAL HOMEOSTASIS 45 570 8.959e-12 1.362e-10
307 MUSCLE CELL DIFFERENTIATION 28 237 9.197e-12 1.394e-10
308 MYELOID CELL DIFFERENTIATION 25 189 1.008e-11 1.522e-10
309 POSITIVE REGULATION OF MAP KINASE ACTIVITY 26 207 1.277e-11 1.923e-10
310 FAT CELL DIFFERENTIATION 19 106 1.449e-11 2.174e-10
311 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 23 162 1.572e-11 2.352e-10
312 MESENCHYMAL CELL DIFFERENTIATION 21 134 1.781e-11 2.656e-10
313 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 20 121 1.984e-11 2.949e-10
314 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 21 135 2.061e-11 3.044e-10
315 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 27 228 2.058e-11 3.044e-10
316 MULTI ORGANISM REPRODUCTIVE PROCESS 58 891 2.188e-11 3.222e-10
317 MYELOID LEUKOCYTE DIFFERENTIATION 18 96 2.274e-11 3.321e-10
318 REGULATION OF LEUKOCYTE CHEMOTAXIS 18 96 2.274e-11 3.321e-10
319 POSITIVE REGULATION OF OSSIFICATION 17 84 2.277e-11 3.321e-10
320 GLIAL CELL DIFFERENTIATION 21 136 2.381e-11 3.463e-10
321 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 34 360 3.024e-11 4.384e-10
322 REGULATION OF MYELOID CELL DIFFERENTIATION 24 183 3.157e-11 4.562e-10
323 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 35 381 3.339e-11 4.811e-10
324 INTERSPECIES INTERACTION BETWEEN ORGANISMS 48 662 3.524e-11 5.045e-10
325 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 48 662 3.524e-11 5.045e-10
326 CELLULAR RESPONSE TO OXIDATIVE STRESS 24 184 3.548e-11 5.064e-10
327 HEAD DEVELOPMENT 50 709 3.616e-11 5.145e-10
328 AMEBOIDAL TYPE CELL MIGRATION 22 154 3.855e-11 5.469e-10
329 REGULATION OF METAL ION TRANSPORT 32 325 3.971e-11 5.599e-10
330 REGULATION OF OSTEOBLAST DIFFERENTIATION 19 112 3.961e-11 5.599e-10
331 TISSUE REMODELING 17 87 4.115e-11 5.785e-10
332 APOPTOTIC SIGNALING PATHWAY 30 289 4.437e-11 6.219e-10
333 REGULATION OF STEM CELL DIFFERENTIATION 19 113 4.653e-11 6.502e-10
334 REGULATION OF CHEMOKINE PRODUCTION 15 65 4.704e-11 6.534e-10
335 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 15 65 4.704e-11 6.534e-10
336 EMBRYONIC ORGAN DEVELOPMENT 36 406 4.749e-11 6.577e-10
337 POSITIVE REGULATION OF BINDING 20 127 4.942e-11 6.823e-10
338 NEGATIVE REGULATION OF PROTEOLYSIS 32 329 5.464e-11 7.522e-10
339 REGULATION OF ERK1 AND ERK2 CASCADE 27 238 5.586e-11 7.667e-10
340 POSITIVE REGULATION OF SECRETION 34 370 6.378e-11 8.729e-10
341 REGULATION OF CELL GROWTH 35 391 6.855e-11 9.353e-10
342 RESPONSE TO INTERFERON GAMMA 21 144 7.235e-11 9.815e-10
343 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 21 144 7.235e-11 9.815e-10
344 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 34 372 7.38e-11 9.983e-10
345 HOMEOSTASIS OF NUMBER OF CELLS 23 175 7.813e-11 1.054e-09
346 REGULATION OF ORGAN MORPHOGENESIS 27 242 8.202e-11 1.103e-09
347 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 19 118 1.015e-10 1.361e-09
348 UROGENITAL SYSTEM DEVELOPMENT 30 299 1.032e-10 1.38e-09
349 CELLULAR RESPONSE TO MECHANICAL STIMULUS 16 80 1.07e-10 1.426e-09
350 CARTILAGE DEVELOPMENT 21 147 1.076e-10 1.43e-09
351 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 27 246 1.194e-10 1.583e-09
352 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 16 81 1.303e-10 1.717e-09
353 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 16 81 1.303e-10 1.717e-09
354 CYTOKINE PRODUCTION 19 120 1.37e-10 1.801e-09
355 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 24 197 1.507e-10 1.97e-09
356 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 24 197 1.507e-10 1.97e-09
357 ENDOCYTOSIS 40 509 1.558e-10 2.031e-09
358 LEUKOCYTE HOMEOSTASIS 14 60 1.786e-10 2.321e-09
359 RESPONSE TO PROGESTERONE 13 50 1.854e-10 2.403e-09
360 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 25 216 1.89e-10 2.443e-09
361 EYE DEVELOPMENT 31 326 1.939e-10 2.499e-09
362 ACTIVATION OF IMMUNE RESPONSE 36 427 1.952e-10 2.502e-09
363 MULTICELLULAR ORGANISM REPRODUCTION 51 768 1.951e-10 2.502e-09
364 CARDIOCYTE DIFFERENTIATION 17 96 2.109e-10 2.696e-09
365 NEGATIVE REGULATION OF CELL CELL ADHESION 20 138 2.306e-10 2.932e-09
366 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 25 218 2.305e-10 2.932e-09
367 POSITIVE REGULATION OF DNA METABOLIC PROCESS 23 185 2.426e-10 3.075e-09
368 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 26 236 2.438e-10 3.083e-09
369 REGULATION OF WNT SIGNALING PATHWAY 30 310 2.501e-10 3.154e-09
370 CELL CYCLE ARREST 21 154 2.613e-10 3.286e-09
371 PEPTIDYL TYROSINE MODIFICATION 23 186 2.705e-10 3.392e-09
372 POSITIVE REGULATION OF CELL CYCLE 31 332 3.055e-10 3.821e-09
373 ACTIVATION OF INNATE IMMUNE RESPONSE 24 204 3.124e-10 3.897e-09
374 MUSCLE ORGAN DEVELOPMENT 28 277 3.693e-10 4.588e-09
375 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 36 437 3.697e-10 4.588e-09
376 REGULATION OF PROTEIN COMPLEX ASSEMBLY 33 375 3.795e-10 4.696e-09
377 PLATELET ACTIVATION 20 142 3.888e-10 4.799e-09
378 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 207 4.228e-10 5.204e-09
379 RESPONSE TO REACTIVE OXYGEN SPECIES 23 191 4.612e-10 5.662e-09
380 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 88 4.783e-10 5.841e-09
381 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 16 88 4.783e-10 5.841e-09
382 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 17 101 4.824e-10 5.876e-09
383 EXTRACELLULAR MATRIX DISASSEMBLY 15 76 5.012e-10 6.088e-09
384 REGULATION OF CALCIUM ION TRANSPORT 24 209 5.156e-10 6.247e-09
385 REGULATION OF LIPID METABOLIC PROCESS 28 282 5.572e-10 6.735e-09
386 RESPONSE TO IONIZING RADIATION 20 145 5.683e-10 6.833e-09
387 NEGATIVE REGULATION OF MAPK CASCADE 20 145 5.683e-10 6.833e-09
388 SKIN DEVELOPMENT 24 211 6.272e-10 7.522e-09
389 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 19 131 6.432e-10 7.694e-09
390 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 25 229 6.575e-10 7.844e-09
391 MAMMARY GLAND DEVELOPMENT 18 117 6.818e-10 8.114e-09
392 REGULATION OF CELL PROJECTION ORGANIZATION 41 558 6.927e-10 8.223e-09
393 REGULATION OF T CELL PROLIFERATION 20 147 7.279e-10 8.619e-09
394 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 34 406 7.544e-10 8.91e-09
395 RESPONSE TO CAMP 17 104 7.737e-10 9.114e-09
396 POSITIVE REGULATION OF NEURON DIFFERENTIATION 29 306 8.175e-10 9.605e-09
397 POSITIVE REGULATION OF CELL GROWTH 20 148 8.225e-10 9.616e-09
398 RESPONSE TO TRANSITION METAL NANOPARTICLE 20 148 8.225e-10 9.616e-09
399 REGULATION OF ANATOMICAL STRUCTURE SIZE 37 472 8.357e-10 9.745e-09
400 CELL AGING 14 67 8.589e-10 9.991e-09
401 ADAPTIVE IMMUNE RESPONSE 28 288 9.014e-10 1.046e-08
402 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 14 68 1.057e-09 1.224e-08
403 REGULATION OF ION TRANSPORT 42 592 1.224e-09 1.413e-08
404 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 19 136 1.232e-09 1.419e-08
405 REGULATION OF CYTOSKELETON ORGANIZATION 38 502 1.31e-09 1.505e-08
406 NEGATIVE REGULATION OF TRANSPORT 36 458 1.325e-09 1.514e-08
407 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 16 94 1.322e-09 1.514e-08
408 REGULATION OF PROTEIN BINDING 21 168 1.332e-09 1.516e-08
409 RESPONSE TO CARBOHYDRATE 21 168 1.332e-09 1.516e-08
410 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 11 38 1.34e-09 1.52e-08
411 CELLULAR RESPONSE TO INTERFERON GAMMA 18 122 1.37e-09 1.551e-08
412 ENDOCRINE SYSTEM DEVELOPMENT 18 123 1.569e-09 1.772e-08
413 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 17 109 1.639e-09 1.847e-08
414 ORGAN REGENERATION 15 83 1.829e-09 2.056e-08
415 FORMATION OF PRIMARY GERM LAYER 17 110 1.895e-09 2.124e-08
416 CELL CYCLE PROCESS 61 1081 1.919e-09 2.146e-08
417 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 12 49 1.989e-09 2.22e-08
418 BONE DEVELOPMENT 20 156 2.108e-09 2.34e-08
419 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 20 156 2.108e-09 2.34e-08
420 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 13 60 2.151e-09 2.377e-08
421 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 2.151e-09 2.377e-08
422 REGULATION OF WOUND HEALING 18 126 2.335e-09 2.574e-08
423 REGULATION OF MITOTIC CELL CYCLE 36 468 2.362e-09 2.598e-08
424 RESPONSE TO VITAMIN 16 98 2.491e-09 2.733e-08
425 RESPONSE TO AMINO ACID 17 112 2.52e-09 2.758e-08
426 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 2.559e-09 2.795e-08
427 RESPONSE TO NUTRIENT 22 191 2.576e-09 2.807e-08
428 NEGATIVE REGULATION OF CELL DEVELOPMENT 28 303 2.832e-09 3.058e-08
429 POSITIVE REGULATION OF STAT CASCADE 14 73 2.83e-09 3.058e-08
430 POSITIVE REGULATION OF JAK STAT CASCADE 14 73 2.83e-09 3.058e-08
431 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 28 303 2.832e-09 3.058e-08
432 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 16 99 2.904e-09 3.12e-08
433 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 17 113 2.898e-09 3.12e-08
434 RESPONSE TO VIRUS 25 247 3.189e-09 3.419e-08
435 CELL CYCLE 69 1316 3.224e-09 3.448e-08
436 CIRCULATORY SYSTEM PROCESS 31 366 3.29e-09 3.511e-08
437 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 3.612e-09 3.794e-08
438 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 3.612e-09 3.794e-08
439 VIRAL ENTRY INTO HOST CELL 15 87 3.612e-09 3.794e-08
440 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 3.612e-09 3.794e-08
441 MOVEMENT IN HOST ENVIRONMENT 15 87 3.612e-09 3.794e-08
442 ENTRY INTO HOST 15 87 3.612e-09 3.794e-08
443 ENTRY INTO HOST CELL 15 87 3.612e-09 3.794e-08
444 RESPONSE TO INTERLEUKIN 1 17 115 3.818e-09 3.984e-08
445 CELLULAR RESPONSE TO ALCOHOL 17 115 3.818e-09 3.984e-08
446 REGULATION OF MUSCLE SYSTEM PROCESS 22 195 3.808e-09 3.984e-08
447 REGULATION OF VITAMIN METABOLIC PROCESS 7 12 4.046e-09 4.212e-08
448 REGULATION OF CARTILAGE DEVELOPMENT 13 63 4.07e-09 4.228e-08
449 RESPONSE TO ESTRADIOL 19 146 4.142e-09 4.292e-08
450 POSITIVE REGULATION OF DNA BINDING 11 42 4.356e-09 4.504e-08
451 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 102 4.549e-09 4.693e-08
452 CELL CELL SIGNALING 48 767 4.77e-09 4.91e-08
453 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 12 53 5.255e-09 5.398e-08
454 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 46 720 5.391e-09 5.525e-08
455 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 22 199 5.569e-09 5.695e-08
456 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 26 274 6.043e-09 6.166e-08
457 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 32 397 6.123e-09 6.234e-08
458 REGULATION OF ION HOMEOSTASIS 22 201 6.71e-09 6.817e-08
459 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 15 92 8.021e-09 8.131e-08
460 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 14 79 8.308e-09 8.386e-08
461 BONE MORPHOGENESIS 14 79 8.308e-09 8.386e-08
462 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 17 121 8.429e-09 8.489e-08
463 CELLULAR COMPONENT DISASSEMBLY 37 515 8.849e-09 8.893e-08
464 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 67 9.009e-09 9.034e-08
465 MULTICELLULAR ORGANISM METABOLIC PROCESS 15 93 9.348e-09 9.354e-08
466 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 17 122 9.572e-09 9.557e-08
467 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 11 45 9.654e-09 9.619e-08
468 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 14 80 9.844e-09 9.787e-08
469 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 154 1.015e-08 1.007e-07
470 REGULATION OF NEURON PROJECTION DEVELOPMENT 32 408 1.18e-08 1.169e-07
471 RESPONSE TO HYDROGEN PEROXIDE 16 109 1.219e-08 1.204e-07
472 INOSITOL LIPID MEDIATED SIGNALING 17 124 1.229e-08 1.212e-07
473 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 24 245 1.256e-08 1.235e-07
474 STRIATED MUSCLE CELL DIFFERENTIATION 20 173 1.285e-08 1.261e-07
475 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 39 573 1.533e-08 1.502e-07
476 NEGATIVE REGULATION OF CELL ACTIVATION 19 158 1.554e-08 1.519e-07
477 REGULATION OF INTERLEUKIN 1 PRODUCTION 12 58 1.569e-08 1.53e-07
478 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 13 70 1.575e-08 1.533e-07
479 DEFENSE RESPONSE TO OTHER ORGANISM 36 505 1.729e-08 1.679e-07
480 ION HOMEOSTASIS 39 576 1.767e-08 1.713e-07
481 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 11 48 2.009e-08 1.943e-07
482 REGULATION OF JAK STAT CASCADE 18 144 2.018e-08 1.944e-07
483 REGULATION OF STAT CASCADE 18 144 2.018e-08 1.944e-07
484 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 23 233 2.191e-08 2.107e-07
485 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 18 145 2.252e-08 2.16e-07
486 CHONDROCYTE DIFFERENTIATION 12 60 2.353e-08 2.253e-07
487 REGULATION OF CATABOLIC PROCESS 45 731 2.429e-08 2.32e-07
488 CELLULAR RESPONSE TO PEPTIDE 25 274 2.601e-08 2.48e-07
489 REGULATION OF ORGAN GROWTH 13 73 2.674e-08 2.544e-07
490 NEGATIVE REGULATION OF GROWTH 23 236 2.785e-08 2.645e-07
491 CYTOSKELETON ORGANIZATION 49 838 2.854e-08 2.704e-07
492 REGULATION OF IMMUNE EFFECTOR PROCESS 32 424 2.933e-08 2.774e-07
493 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 15 101 2.966e-08 2.8e-07
494 LYMPHOCYTE HOMEOSTASIS 11 50 3.175e-08 2.984e-07
495 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 74 3.171e-08 2.984e-07
496 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 17 132 3.187e-08 2.984e-07
497 REGULATION OF LYMPHOCYTE DIFFERENTIATION 17 132 3.187e-08 2.984e-07
498 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 15 102 3.399e-08 3.176e-07
499 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 24 258 3.42e-08 3.189e-07
500 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 12 62 3.472e-08 3.231e-07
501 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 13 75 3.749e-08 3.482e-07
502 SYSTEM PROCESS 82 1785 3.811e-08 3.532e-07
503 NEURON PROJECTION DEVELOPMENT 37 545 3.881e-08 3.59e-07
504 REGULATION OF INTERLEUKIN 12 PRODUCTION 11 51 3.958e-08 3.654e-07
505 INTERACTION WITH HOST 17 134 3.997e-08 3.677e-07
506 NEGATIVE REGULATION OF CATABOLIC PROCESS 21 203 3.999e-08 3.677e-07
507 DIVALENT INORGANIC CATION HOMEOSTASIS 28 343 4.229e-08 3.882e-07
508 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 9 31 4.239e-08 3.882e-07
509 CELL PROJECTION ORGANIZATION 51 902 4.292e-08 3.924e-07
510 EPITHELIAL CELL DEVELOPMENT 20 186 4.41e-08 4.023e-07
511 REGULATION OF INTERLEUKIN 6 PRODUCTION 15 104 4.442e-08 4.045e-07
512 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 10 41 4.695e-08 4.262e-07
513 REGULATION OF OXIDOREDUCTASE ACTIVITY 14 90 4.699e-08 4.262e-07
514 TISSUE REGENERATION 11 52 4.909e-08 4.435e-07
515 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 11 52 4.909e-08 4.435e-07
516 RESPONSE TO ETHANOL 17 136 4.993e-08 4.502e-07
517 GLUCOSE HOMEOSTASIS 19 170 5.148e-08 4.624e-07
518 CARBOHYDRATE HOMEOSTASIS 19 170 5.148e-08 4.624e-07
519 CIRCADIAN RHYTHM 17 137 5.571e-08 4.995e-07
520 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 15 106 5.768e-08 5.161e-07
521 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 6.057e-08 5.399e-07
522 CELLULAR RESPONSE TO AMINO ACID STIMULUS 11 53 6.057e-08 5.399e-07
523 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 19 172 6.218e-08 5.532e-07
524 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 20 190 6.3e-08 5.594e-07
525 TELENCEPHALON DEVELOPMENT 22 228 6.674e-08 5.915e-07
526 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 17 139 6.915e-08 6.117e-07
527 REGULATION OF DNA BINDING 14 93 7.203e-08 6.359e-07
528 ALPHA BETA T CELL ACTIVATION 11 54 7.437e-08 6.554e-07
529 POSITIVE REGULATION OF NEURON DEATH 12 67 8.61e-08 7.573e-07
530 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 11 55 9.09e-08 7.952e-07
531 REGULATION OF KIDNEY DEVELOPMENT 11 55 9.09e-08 7.952e-07
532 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 22 232 9.092e-08 7.952e-07
533 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 95 9.485e-08 8.28e-07
534 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 13 81 9.704e-08 8.455e-07
535 RESPONSE TO TUMOR NECROSIS FACTOR 22 233 9.812e-08 8.533e-07
536 EPIDERMIS DEVELOPMENT 23 253 1.007e-07 8.74e-07
537 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 34 1.032e-07 8.941e-07
538 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 56 1.106e-07 9.548e-07
539 OUTFLOW TRACT MORPHOGENESIS 11 56 1.106e-07 9.548e-07
540 RESPIRATORY SYSTEM DEVELOPMENT 20 197 1.149e-07 9.882e-07
541 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 20 197 1.149e-07 9.882e-07
542 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 19 179 1.178e-07 1.011e-06
543 NEGATIVE REGULATION OF OSSIFICATION 12 69 1.21e-07 1.037e-06
544 ALPHA BETA T CELL DIFFERENTIATION 10 45 1.222e-07 1.045e-06
545 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 16 128 1.235e-07 1.055e-06
546 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 18 162 1.265e-07 1.078e-06
547 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 17 145 1.292e-07 1.099e-06
548 DEFENSE RESPONSE TO BACTERIUM 22 237 1.325e-07 1.125e-06
549 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 11 57 1.34e-07 1.134e-06
550 ENDOTHELIAL CELL MIGRATION 11 57 1.34e-07 1.134e-06
551 REGULATION OF ENDOCYTOSIS 20 199 1.357e-07 1.146e-06
552 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 14 98 1.414e-07 1.192e-06
553 TISSUE MIGRATION 13 84 1.511e-07 1.272e-06
554 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 46 1.527e-07 1.28e-06
555 REGULATION OF CHONDROCYTE DIFFERENTIATION 10 46 1.527e-07 1.28e-06
556 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 29 387 1.536e-07 1.285e-06
557 SKELETAL SYSTEM MORPHOGENESIS 20 201 1.599e-07 1.336e-06
558 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 11 58 1.617e-07 1.346e-06
559 UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 11 58 1.617e-07 1.346e-06
560 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 13 85 1.744e-07 1.447e-06
561 TOLL LIKE RECEPTOR SIGNALING PATHWAY 13 85 1.744e-07 1.447e-06
562 REGULATION OF ERYTHROCYTE DIFFERENTIATION 9 36 1.772e-07 1.464e-06
563 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 9 36 1.772e-07 1.464e-06
564 THYMUS DEVELOPMENT 10 47 1.897e-07 1.562e-06
565 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 262 1.896e-07 1.562e-06
566 MAINTENANCE OF CELL NUMBER 16 132 1.903e-07 1.564e-06
567 POSITIVE REGULATION OF DNA REPLICATION 13 86 2.009e-07 1.649e-06
568 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 16 133 2.114e-07 1.732e-06
569 NEURON PROJECTION GUIDANCE 20 205 2.206e-07 1.804e-06
570 GLIAL CELL MIGRATION 9 37 2.29e-07 1.869e-06
571 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 12 73 2.305e-07 1.875e-06
572 ACUTE INFLAMMATORY RESPONSE 12 73 2.305e-07 1.875e-06
573 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 10 48 2.343e-07 1.903e-06
574 NEURON DEVELOPMENT 41 687 2.4e-07 1.945e-06
575 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 19 188 2.556e-07 2.069e-06
576 REGULATION OF COAGULATION 13 88 2.649e-07 2.136e-06
577 REGULATION OF STEM CELL PROLIFERATION 13 88 2.649e-07 2.136e-06
578 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 103 2.662e-07 2.143e-06
579 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 12 74 2.69e-07 2.158e-06
580 CARDIAC MUSCLE CELL DIFFERENTIATION 12 74 2.69e-07 2.158e-06
581 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 11 61 2.776e-07 2.219e-06
582 REGULATION OF INTERLEUKIN 8 PRODUCTION 11 61 2.776e-07 2.219e-06
583 PALLIUM DEVELOPMENT 17 153 2.827e-07 2.256e-06
584 REGULATION OF STEROID BIOSYNTHETIC PROCESS 10 49 2.879e-07 2.294e-06
585 CARDIAC CHAMBER MORPHOGENESIS 14 104 3.007e-07 2.388e-06
586 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 14 104 3.007e-07 2.388e-06
587 ARTERY DEVELOPMENT 12 75 3.131e-07 2.478e-06
588 NEURAL CREST CELL DIFFERENTIATION 12 75 3.131e-07 2.478e-06
589 PARTURITION 7 20 3.33e-07 2.626e-06
590 REGULATION OF MONOCYTE CHEMOTAXIS 7 20 3.33e-07 2.626e-06
591 ODONTOGENESIS 14 105 3.392e-07 2.671e-06
592 GASTRULATION 17 155 3.409e-07 2.677e-06
593 NEURON PROJECTION MORPHOGENESIS 29 402 3.411e-07 2.677e-06
594 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 6 13 3.421e-07 2.68e-06
595 FOREBRAIN DEVELOPMENT 27 357 3.445e-07 2.694e-06
596 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 10 50 3.519e-07 2.734e-06
597 STAT CASCADE 10 50 3.519e-07 2.734e-06
598 JAK STAT CASCADE 10 50 3.519e-07 2.734e-06
599 RESPONSE TO GAMMA RADIATION 10 50 3.519e-07 2.734e-06
600 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 9 39 3.732e-07 2.886e-06
601 ASTROCYTE DIFFERENTIATION 9 39 3.732e-07 2.886e-06
602 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 17 156 3.739e-07 2.886e-06
603 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 17 156 3.739e-07 2.886e-06
604 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 3.784e-07 2.905e-06
605 REGULATION OF HEART MORPHOGENESIS 8 29 3.784e-07 2.905e-06
606 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 29 3.784e-07 2.905e-06
607 REGULATION OF EPIDERMIS DEVELOPMENT 11 63 3.909e-07 2.996e-06
608 POSITIVE REGULATION OF MITOTIC CELL CYCLE 15 123 4.234e-07 3.241e-06
609 REGULATION OF SEQUESTERING OF CALCIUM ION 14 107 4.297e-07 3.279e-06
610 CARDIAC MUSCLE TISSUE DEVELOPMENT 16 140 4.299e-07 3.279e-06
611 EAR DEVELOPMENT 19 195 4.515e-07 3.439e-06
612 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 4.615e-07 3.509e-06
613 ENDOCRINE PANCREAS DEVELOPMENT 9 40 4.71e-07 3.569e-06
614 ENDODERMAL CELL DIFFERENTIATION 9 40 4.71e-07 3.569e-06
615 RENAL TUBULE DEVELOPMENT 12 78 4.865e-07 3.681e-06
616 REGULATION OF JNK CASCADE 17 159 4.913e-07 3.711e-06
617 POSITIVE REGULATION OF BLOOD CIRCULATION 13 93 5.113e-07 3.856e-06
618 POSITIVE REGULATION OF ION TRANSPORT 21 236 5.166e-07 3.889e-06
619 CELLULAR RESPONSE TO RETINOIC ACID 11 65 5.432e-07 4.084e-06
620 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 12 79 5.609e-07 4.209e-06
621 OSTEOBLAST DIFFERENTIATION 15 126 5.803e-07 4.348e-06
622 T CELL MIGRATION 6 14 5.861e-07 4.378e-06
623 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 14 5.861e-07 4.378e-06
624 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 41 5.903e-07 4.38e-06
625 AORTA DEVELOPMENT 9 41 5.903e-07 4.38e-06
626 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 9 41 5.903e-07 4.38e-06
627 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 41 5.903e-07 4.38e-06
628 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 12 80 6.451e-07 4.78e-06
629 POSITIVE REGULATION OF T CELL PROLIFERATION 13 95 6.57e-07 4.86e-06
630 NEGATIVE REGULATION OF SECRETION 19 200 6.667e-07 4.924e-06
631 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 22 7.016e-07 5.141e-06
632 REGULATION OF RESPONSE TO INTERFERON GAMMA 7 22 7.016e-07 5.141e-06
633 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 7 22 7.016e-07 5.141e-06
634 AORTA MORPHOGENESIS 7 22 7.016e-07 5.141e-06
635 VASCULAR PROCESS IN CIRCULATORY SYSTEM 17 163 6.996e-07 5.141e-06
636 REGULATION OF LIPID BIOSYNTHETIC PROCESS 15 128 7.122e-07 5.211e-06
637 RESPONSE TO TOXIC SUBSTANCE 21 241 7.293e-07 5.328e-06
638 REGULATION OF HEART GROWTH 9 42 7.348e-07 5.359e-06
639 REGULATION OF FIBROBLAST PROLIFERATION 12 81 7.405e-07 5.392e-06
640 PROTEIN COMPLEX BIOGENESIS 56 1132 7.495e-07 5.435e-06
641 POSITIVE REGULATION OF CALCIUM ION IMPORT 10 54 7.499e-07 5.435e-06
642 PROTEIN COMPLEX ASSEMBLY 56 1132 7.495e-07 5.435e-06
643 BEHAVIOR 33 516 8.266e-07 5.982e-06
644 REGULATION OF MUSCLE CONTRACTION 16 147 8.359e-07 6.039e-06
645 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 26 351 8.438e-07 6.087e-06
646 KIDNEY MORPHOGENESIS 12 82 8.481e-07 6.108e-06
647 SALIVARY GLAND DEVELOPMENT 8 32 8.683e-07 6.225e-06
648 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 8 32 8.683e-07 6.225e-06
649 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 32 8.683e-07 6.225e-06
650 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 11 68 8.699e-07 6.227e-06
651 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 10 55 8.963e-07 6.406e-06
652 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 9 43 9.09e-07 6.477e-06
653 ACUTE PHASE RESPONSE 9 43 9.09e-07 6.477e-06
654 DIGESTIVE SYSTEM DEVELOPMENT 16 148 9.161e-07 6.517e-06
655 POSITIVE REGULATION OF ENDOCYTOSIS 14 114 9.422e-07 6.693e-06
656 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 98 9.453e-07 6.705e-06
657 EMBRYONIC PLACENTA DEVELOPMENT 12 83 9.693e-07 6.865e-06
658 RESPONSE TO INSULIN 19 205 9.718e-07 6.872e-06
659 RESPONSE TO INCREASED OXYGEN LEVELS 7 23 9.87e-07 6.948e-06
660 LEUKOCYTE APOPTOTIC PROCESS 7 23 9.87e-07 6.948e-06
661 RESPONSE TO HYPEROXIA 7 23 9.87e-07 6.948e-06
662 POSITIVE REGULATION OF AXONOGENESIS 11 69 1.012e-06 7.113e-06
663 NEPHRON DEVELOPMENT 14 115 1.049e-06 7.36e-06
664 LIPID PHOSPHORYLATION 13 99 1.064e-06 7.455e-06
665 EPITHELIAL TO MESENCHYMAL TRANSITION 10 56 1.067e-06 7.467e-06
666 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 17 168 1.071e-06 7.483e-06
667 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 12 84 1.106e-06 7.713e-06
668 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 9 44 1.118e-06 7.774e-06
669 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 9 44 1.118e-06 7.774e-06
670 CELLULAR SENESCENCE 8 33 1.121e-06 7.787e-06
671 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 19 208 1.211e-06 8.397e-06
672 POSITIVE REGULATION OF CELL CYCLE ARREST 12 85 1.259e-06 8.716e-06
673 CIRCADIAN REGULATION OF GENE EXPRESSION 10 57 1.266e-06 8.738e-06
674 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 10 57 1.266e-06 8.738e-06
675 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 11 71 1.358e-06 9.364e-06
676 EXOCRINE SYSTEM DEVELOPMENT 9 45 1.367e-06 9.407e-06
677 SINGLE ORGANISM BEHAVIOR 27 384 1.423e-06 9.781e-06
678 PROTEIN KINASE B SIGNALING 8 34 1.435e-06 9.831e-06
679 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 8 34 1.435e-06 9.831e-06
680 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 18 191 1.471e-06 1.007e-05
681 EYE MORPHOGENESIS 15 136 1.553e-06 1.061e-05
682 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 16 154 1.561e-06 1.065e-05
683 NEGATIVE REGULATION OF CYTOKINE SECRETION 9 46 1.662e-06 1.132e-05
684 REGULATION OF CELL CYCLE PROCESS 34 558 1.67e-06 1.136e-05
685 REGULATION OF CALCIUM ION IMPORT 13 103 1.682e-06 1.142e-05
686 SKELETAL MUSCLE ORGAN DEVELOPMENT 15 137 1.705e-06 1.154e-05
687 ACTIVATION OF MAPK ACTIVITY 15 137 1.705e-06 1.154e-05
688 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 10 59 1.761e-06 1.191e-05
689 CELLULAR RESPONSE TO KETONE 11 73 1.805e-06 1.217e-05
690 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 11 73 1.805e-06 1.217e-05
691 NEGATIVE REGULATION OF PROTEIN PROCESSING 8 35 1.819e-06 1.223e-05
692 NEGATIVE REGULATION OF PROTEIN MATURATION 8 35 1.819e-06 1.223e-05
693 MYELOID CELL HOMEOSTASIS 12 88 1.837e-06 1.231e-05
694 CELLULAR RESPONSE TO INTERLEUKIN 1 12 88 1.837e-06 1.231e-05
695 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 16 156 1.853e-06 1.239e-05
696 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 16 156 1.853e-06 1.239e-05
697 REGULATION OF B CELL ACTIVATION 14 121 1.946e-06 1.299e-05
698 SECRETION 35 588 1.989e-06 1.326e-05
699 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 9 47 2.011e-06 1.338e-05
700 REGULATION OF SMOOTH MUSCLE CONTRACTION 10 60 2.067e-06 1.374e-05
701 B CELL DIFFERENTIATION 12 89 2.075e-06 1.376e-05
702 EPITHELIAL CELL PROLIFERATION 12 89 2.075e-06 1.376e-05
703 CEREBRAL CORTEX DEVELOPMENT 13 105 2.097e-06 1.388e-05
704 EMBRYONIC ORGAN MORPHOGENESIS 22 279 2.132e-06 1.409e-05
705 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 22 280 2.262e-06 1.49e-05
706 NEGATIVE REGULATION OF ANOIKIS 6 17 2.266e-06 1.49e-05
707 POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 17 2.266e-06 1.49e-05
708 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 6 17 2.266e-06 1.49e-05
709 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 36 2.289e-06 1.5e-05
710 T CELL SELECTION 8 36 2.289e-06 1.5e-05
711 MESONEPHROS DEVELOPMENT 12 90 2.341e-06 1.532e-05
712 REGULATION OF ADAPTIVE IMMUNE RESPONSE 14 123 2.371e-06 1.55e-05
713 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 11 75 2.376e-06 1.551e-05
714 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 9 48 2.421e-06 1.577e-05
715 DEVELOPMENTAL PROGRAMMED CELL DEATH 7 26 2.482e-06 1.615e-05
716 SENSORY ORGAN MORPHOGENESIS 20 239 2.503e-06 1.627e-05
717 REGULATION OF T CELL DIFFERENTIATION 13 107 2.6e-06 1.685e-05
718 RESPONSE TO RETINOIC ACID 13 107 2.6e-06 1.685e-05
719 VESICLE MEDIATED TRANSPORT 58 1239 2.699e-06 1.747e-05
720 REGULATION OF DNA REPLICATION 16 161 2.81e-06 1.816e-05
721 MYOBLAST DIFFERENTIATION 8 37 2.857e-06 1.841e-05
722 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 2.857e-06 1.841e-05
723 KIDNEY EPITHELIUM DEVELOPMENT 14 125 2.877e-06 1.851e-05
724 REGULATION OF CELL CYCLE ARREST 13 108 2.89e-06 1.857e-05
725 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 49 2.9e-06 1.859e-05
726 LYMPHOCYTE MIGRATION 9 49 2.9e-06 1.859e-05
727 CELLULAR RESPONSE TO OXYGEN LEVELS 15 143 2.928e-06 1.874e-05
728 REGULATION OF BMP SIGNALING PATHWAY 11 77 3.099e-06 1.981e-05
729 REGULATION OF MICROTUBULE BASED PROCESS 20 243 3.227e-06 2.06e-05
730 DETECTION OF BIOTIC STIMULUS 7 27 3.279e-06 2.084e-05
731 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 3.279e-06 2.084e-05
732 REGULATION OF MUSCLE ADAPTATION 10 63 3.278e-06 2.084e-05
733 NEPHRON EPITHELIUM DEVELOPMENT 12 93 3.329e-06 2.11e-05
734 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 6 18 3.328e-06 2.11e-05
735 ENDODERM FORMATION 9 50 3.46e-06 2.19e-05
736 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 10 64 3.799e-06 2.402e-05
737 POSITIVE REGULATION OF HAIR CYCLE 5 11 3.829e-06 2.417e-05
738 CELL JUNCTION ORGANIZATION 17 185 4.049e-06 2.553e-05
739 ARTERY MORPHOGENESIS 9 51 4.109e-06 2.587e-05
740 POSITIVE REGULATION OF CELL CYCLE PROCESS 20 247 4.136e-06 2.6e-05
741 REGULATION OF EPITHELIAL CELL MIGRATION 16 166 4.189e-06 2.631e-05
742 RESPONSE TO COPPER ION 7 28 4.279e-06 2.683e-05
743 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 8 39 4.358e-06 2.722e-05
744 REGULATION OF GRANULOCYTE CHEMOTAXIS 8 39 4.358e-06 2.722e-05
745 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 39 4.358e-06 2.722e-05
746 PEPTIDYL SERINE MODIFICATION 15 148 4.494e-06 2.803e-05
747 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 12 96 4.666e-06 2.906e-05
748 DETECTION OF OTHER ORGANISM 6 19 4.762e-06 2.962e-05
749 OVULATION CYCLE 13 113 4.812e-06 2.989e-05
750 ACTIVATION OF MAPKK ACTIVITY 9 52 4.861e-06 3.016e-05
751 REGULATION OF AXONOGENESIS 16 168 4.893e-06 3.031e-05
752 NEGATIVE REGULATION OF KINASE ACTIVITY 20 250 4.963e-06 3.071e-05
753 NEGATIVE REGULATION OF BINDING 14 131 5.017e-06 3.1e-05
754 REGULATION OF CELL DIVISION 21 272 5.045e-06 3.109e-05
755 MULTICELLULAR ORGANISMAL HOMEOSTASIS 21 272 5.045e-06 3.109e-05
756 MESODERM MORPHOGENESIS 10 66 5.061e-06 3.111e-05
757 REGULATION OF VASOCONSTRICTION 10 66 5.061e-06 3.111e-05
758 METANEPHROS DEVELOPMENT 11 81 5.142e-06 3.156e-05
759 REGULATION OF INTERFERON GAMMA PRODUCTION 12 97 5.206e-06 3.192e-05
760 REGULATION OF BLOOD CIRCULATION 22 295 5.278e-06 3.232e-05
761 MAMMARY GLAND MORPHOGENESIS 8 40 5.329e-06 3.258e-05
762 LEUKOCYTE MEDIATED IMMUNITY 17 189 5.405e-06 3.3e-05
763 B CELL ACTIVATION 14 132 5.487e-06 3.346e-05
764 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 7 29 5.52e-06 3.362e-05
765 LIPID MODIFICATION 18 210 5.67e-06 3.449e-05
766 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 5.728e-06 3.47e-05
767 MAMMARY GLAND EPITHELIUM DEVELOPMENT 9 53 5.728e-06 3.47e-05
768 MESONEPHRIC TUBULE MORPHOGENESIS 9 53 5.728e-06 3.47e-05
769 RECEPTOR METABOLIC PROCESS 11 82 5.807e-06 3.509e-05
770 INTEGRIN MEDIATED SIGNALING PATHWAY 11 82 5.807e-06 3.509e-05
771 INTRINSIC APOPTOTIC SIGNALING PATHWAY 15 152 6.246e-06 3.769e-05
772 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 25 368 6.382e-06 3.847e-05
773 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 13 116 6.445e-06 3.874e-05
774 RESPONSE TO FIBROBLAST GROWTH FACTOR 13 116 6.445e-06 3.874e-05
775 MYELOID LEUKOCYTE MIGRATION 12 99 6.454e-06 3.875e-05
776 REGULATION OF LIPASE ACTIVITY 11 83 6.546e-06 3.925e-05
777 REGULATION OF CELL SIZE 16 172 6.625e-06 3.967e-05
778 PROTEIN AUTOPHOSPHORYLATION 17 192 6.676e-06 3.992e-05
779 REGULATION OF PROTEIN CATABOLIC PROCESS 26 393 6.716e-06 4.012e-05
780 MACROMOLECULAR COMPLEX ASSEMBLY 62 1398 6.737e-06 4.019e-05
781 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 15 153 6.769e-06 4.033e-05
782 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 30 7.046e-06 4.177e-05
783 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 30 7.046e-06 4.177e-05
784 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 30 7.046e-06 4.177e-05
785 OSTEOCLAST DIFFERENTIATION 7 30 7.046e-06 4.177e-05
786 REGULATION OF PEPTIDE TRANSPORT 20 256 7.082e-06 4.191e-05
787 SINGLE ORGANISM CELLULAR LOCALIZATION 45 898 7.089e-06 4.191e-05
788 REGULATION OF CELL SUBSTRATE ADHESION 16 173 7.136e-06 4.214e-05
789 MEMBRANE ORGANIZATION 45 899 7.293e-06 4.301e-05
790 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 8 42 7.829e-06 4.611e-05
791 CRANIAL SKELETAL SYSTEM DEVELOPMENT 9 55 7.863e-06 4.625e-05
792 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 11 85 8.274e-06 4.861e-05
793 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 18 216 8.386e-06 4.92e-05
794 RESPONSE TO ALKALOID 14 137 8.47e-06 4.964e-05
795 B CELL HOMEOSTASIS 6 21 9.129e-06 5.343e-05
796 DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 8 43 9.411e-06 5.501e-05
797 ACTIN FILAMENT BASED PROCESS 28 450 9.454e-06 5.52e-05
798 REGULATION OF CIRCADIAN RHYTHM 12 103 9.758e-06 5.69e-05
799 ENDODERM DEVELOPMENT 10 71 9.912e-06 5.772e-05
800 CARDIOBLAST DIFFERENTIATION 5 13 1.023e-05 5.938e-05
801 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 13 1.023e-05 5.938e-05
802 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 13 1.023e-05 5.938e-05
803 ANATOMICAL STRUCTURE HOMEOSTASIS 21 285 1.035e-05 6e-05
804 ENDOCARDIAL CUSHION DEVELOPMENT 7 32 1.116e-05 6.434e-05
805 PATTERNING OF BLOOD VESSELS 7 32 1.116e-05 6.434e-05
806 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 32 1.116e-05 6.434e-05
807 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 7 32 1.116e-05 6.434e-05
808 ENDOTHELIAL CELL DIFFERENTIATION 10 72 1.126e-05 6.451e-05
809 POSITIVE REGULATION OF MUSCLE CONTRACTION 8 44 1.125e-05 6.451e-05
810 CHEMOKINE MEDIATED SIGNALING PATHWAY 10 72 1.126e-05 6.451e-05
811 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 10 72 1.126e-05 6.451e-05
812 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 8 44 1.125e-05 6.451e-05
813 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 22 1.229e-05 6.999e-05
814 REGULATION OF HAIR CYCLE 6 22 1.229e-05 6.999e-05
815 REGULATION OF INTERLEUKIN 17 PRODUCTION 6 22 1.229e-05 6.999e-05
816 REGULATION OF CELLULAR RESPIRATION 6 22 1.229e-05 6.999e-05
817 CELLULAR RESPONSE TO INTERLEUKIN 6 6 22 1.229e-05 6.999e-05
818 SEX DIFFERENTIATION 20 266 1.248e-05 7.099e-05
819 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 10 73 1.276e-05 7.248e-05
820 REGULATION OF ACTIN FILAMENT BASED PROCESS 22 312 1.281e-05 7.262e-05
821 EPIDERMAL CELL DIFFERENTIATION 14 142 1.281e-05 7.262e-05
822 RESPONSE TO HEAT 11 89 1.295e-05 7.331e-05
823 DNA TEMPLATED TRANSCRIPTION INITIATION 17 202 1.307e-05 7.391e-05
824 DENDRITIC CELL DIFFERENTIATION 7 33 1.386e-05 7.789e-05
825 RESPONSE TO VITAMIN D 7 33 1.386e-05 7.789e-05
826 NEGATIVE REGULATION OF JNK CASCADE 7 33 1.386e-05 7.789e-05
827 RESPONSE TO DEXAMETHASONE 7 33 1.386e-05 7.789e-05
828 REGULATION OF CELL AGING 7 33 1.386e-05 7.789e-05
829 LIPID METABOLIC PROCESS 53 1158 1.411e-05 7.921e-05
830 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 11 90 1.443e-05 8.069e-05
831 ENDOTHELIUM DEVELOPMENT 11 90 1.443e-05 8.069e-05
832 REGULATION OF STEROID METABOLIC PROCESS 10 74 1.443e-05 8.069e-05
833 CARDIAC CHAMBER DEVELOPMENT 14 144 1.503e-05 8.397e-05
834 CHROMATIN MODIFICATION 31 539 1.516e-05 8.461e-05
835 REGULATION OF VESICLE MEDIATED TRANSPORT 28 462 1.532e-05 8.539e-05
836 REGULATION OF PODOSOME ASSEMBLY 5 14 1.559e-05 8.638e-05
837 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 5 14 1.559e-05 8.638e-05
838 CRANIOFACIAL SUTURE MORPHOGENESIS 5 14 1.559e-05 8.638e-05
839 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 14 1.559e-05 8.638e-05
840 POST EMBRYONIC ORGAN DEVELOPMENT 5 14 1.559e-05 8.638e-05
841 CELL SUBSTRATE ADHESION 15 164 1.569e-05 8.681e-05
842 NEGATIVE REGULATION OF PROTEIN SECRETION 12 108 1.591e-05 8.779e-05
843 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 12 108 1.591e-05 8.779e-05
844 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 13 126 1.596e-05 8.798e-05
845 REGULATION OF NUCLEASE ACTIVITY 6 23 1.628e-05 8.912e-05
846 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 23 1.628e-05 8.912e-05
847 CELLULAR GLUCOSE HOMEOSTASIS 10 75 1.628e-05 8.912e-05
848 REGULATION OF METANEPHROS DEVELOPMENT 6 23 1.628e-05 8.912e-05
849 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 6 23 1.628e-05 8.912e-05
850 NEUROTROPHIN SIGNALING PATHWAY 6 23 1.628e-05 8.912e-05
851 REGULATION OF MONOOXYGENASE ACTIVITY 9 60 1.637e-05 8.953e-05
852 RESPONSE TO FLUID SHEAR STRESS 7 34 1.708e-05 9.296e-05
853 T CELL HOMEOSTASIS 7 34 1.708e-05 9.296e-05
854 HEART VALVE DEVELOPMENT 7 34 1.708e-05 9.296e-05
855 CELLULAR RESPONSE TO ALKALOID 7 34 1.708e-05 9.296e-05
856 NEGATIVE REGULATION OF ION TRANSPORT 13 127 1.738e-05 9.449e-05
857 COGNITION 19 251 1.865e-05 0.0001013
858 REGULATION OF IMMUNOGLOBULIN PRODUCTION 8 47 1.87e-05 0.0001013
859 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 8 47 1.87e-05 0.0001013
860 POSITIVE REGULATION OF STEM CELL PROLIFERATION 9 61 1.879e-05 0.0001017
861 HEPATICOBILIARY SYSTEM DEVELOPMENT 13 128 1.892e-05 0.0001022
862 REGULATION OF CELL CYCLE PHASE TRANSITION 22 321 1.991e-05 0.0001075
863 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 17 209 2.037e-05 0.0001098
864 RESPONSE TO TEMPERATURE STIMULUS 14 148 2.052e-05 0.0001105
865 MITOTIC CELL CYCLE 39 766 2.075e-05 0.0001116
866 POSITIVE REGULATION OF VASOCONSTRICTION 7 35 2.09e-05 0.0001122
867 BONE REMODELING 7 35 2.09e-05 0.0001122
868 RECEPTOR MEDIATED ENDOCYTOSIS 18 231 2.092e-05 0.0001122
869 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 24 2.125e-05 0.0001131
870 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 6 24 2.125e-05 0.0001131
871 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 24 2.125e-05 0.0001131
872 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 6 24 2.125e-05 0.0001131
873 REGULATION OF ISOTYPE SWITCHING 6 24 2.125e-05 0.0001131
874 REGULATION OF ANOIKIS 6 24 2.125e-05 0.0001131
875 FOREBRAIN CELL MIGRATION 9 62 2.15e-05 0.0001142
876 CARDIAC VENTRICLE MORPHOGENESIS 9 62 2.15e-05 0.0001142
877 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 22 323 2.19e-05 0.0001162
878 REGULATION OF MYOBLAST DIFFERENTIATION 8 48 2.196e-05 0.0001162
879 POSITIVE REGULATION OF WOUND HEALING 8 48 2.196e-05 0.0001162
880 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 5 15 2.291e-05 0.0001203
881 REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 15 2.291e-05 0.0001203
882 NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 5 15 2.291e-05 0.0001203
883 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 5 15 2.291e-05 0.0001203
884 POSITIVE REGULATION OF NUCLEASE ACTIVITY 5 15 2.291e-05 0.0001203
885 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 5 15 2.291e-05 0.0001203
886 T CELL APOPTOTIC PROCESS 5 15 2.291e-05 0.0001203
887 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 17 211 2.303e-05 0.0001208
888 PHAGOCYTOSIS 16 190 2.319e-05 0.0001215
889 CATABOLIC PROCESS 72 1773 2.363e-05 0.0001237
890 REGULATION OF OSTEOCLAST DIFFERENTIATION 9 63 2.454e-05 0.0001281
891 RESPONSE TO OSMOTIC STRESS 9 63 2.454e-05 0.0001281
892 DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE 7 36 2.539e-05 0.0001324
893 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 8 49 2.568e-05 0.0001338
894 NEGATIVE REGULATION OF PROTEIN BINDING 10 79 2.589e-05 0.0001348
895 RESPONSE TO LIGHT STIMULUS 20 280 2.623e-05 0.0001363
896 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 11 96 2.675e-05 0.0001389
897 MONOCARBOXYLIC ACID METABOLIC PROCESS 29 503 2.729e-05 0.0001416
898 REGULATION OF TRANSMEMBRANE TRANSPORT 26 426 2.732e-05 0.0001416
899 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 6 25 2.738e-05 0.0001417
900 FATTY ACID BIOSYNTHETIC PROCESS 12 114 2.753e-05 0.0001423
901 MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 15 172 2.759e-05 0.0001425
902 CHROMOSOME ORGANIZATION 47 1009 2.876e-05 0.0001483
903 MUSCLE SYSTEM PROCESS 20 282 2.903e-05 0.0001496
904 CELLULAR RESPONSE TO CAMP 8 50 2.991e-05 0.000154
905 CELL CYCLE CHECKPOINT 16 194 2.996e-05 0.0001541
906 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 37 3.065e-05 0.0001574
907 REGULATION OF RESPONSE TO OXIDATIVE STRESS 9 65 3.172e-05 0.0001627
908 REGULATION OF JUN KINASE ACTIVITY 10 81 3.229e-05 0.0001655
909 MYELOID LEUKOCYTE ACTIVATION 11 98 3.25e-05 0.0001664
910 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 16 3.265e-05 0.0001664
911 REGULATION OF MONONUCLEAR CELL MIGRATION 5 16 3.265e-05 0.0001664
912 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 16 3.265e-05 0.0001664
913 REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS 5 16 3.265e-05 0.0001664
914 REGULATION OF CELLULAR SENESCENCE 6 26 3.484e-05 0.0001766
915 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 26 3.484e-05 0.0001766
916 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 8 51 3.471e-05 0.0001766
917 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 3.484e-05 0.0001766
918 RESPONSE TO INTERLEUKIN 6 6 26 3.484e-05 0.0001766
919 NEGATIVE REGULATION OF LOCOMOTION 19 263 3.557e-05 0.0001801
920 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 66 3.592e-05 0.0001813
921 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 66 3.592e-05 0.0001813
922 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 9 66 3.592e-05 0.0001813
923 REGULATION OF PROTEIN MATURATION 10 82 3.597e-05 0.0001813
924 LYMPHOCYTE CHEMOTAXIS 7 38 3.677e-05 0.000185
925 MESENCHYME MORPHOGENESIS 7 38 3.677e-05 0.000185
926 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 14 156 3.701e-05 0.0001858
927 PROTEIN LOCALIZATION TO NUCLEUS 14 156 3.701e-05 0.0001858
928 SEXUAL REPRODUCTION 37 730 3.728e-05 0.0001869
929 MESODERM DEVELOPMENT 12 118 3.888e-05 0.0001947
930 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 11 100 3.929e-05 0.0001964
931 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 11 100 3.929e-05 0.0001964
932 REGULATION OF CELLULAR COMPONENT SIZE 22 337 4.167e-05 0.000208
933 VIRAL LIFE CYCLE 20 290 4.313e-05 0.0002151
934 SKELETAL MUSCLE TISSUE REGENERATION 6 27 4.386e-05 0.0002176
935 POSITIVE REGULATION OF HEART GROWTH 6 27 4.386e-05 0.0002176
936 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 7 39 4.386e-05 0.0002176
937 AXIS ELONGATION 6 27 4.386e-05 0.0002176
938 PLATELET AGGREGATION 7 39 4.386e-05 0.0002176
939 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 17 4.531e-05 0.000224
940 MEMBRANE RAFT ORGANIZATION 5 17 4.531e-05 0.000224
941 REGULATION OF RECEPTOR BINDING 5 17 4.531e-05 0.000224
942 MITOTIC CELL CYCLE CHECKPOINT 13 139 4.54e-05 0.0002242
943 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 4.577e-05 0.0002254
944 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 9 68 4.577e-05 0.0002254
945 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 9 68 4.577e-05 0.0002254
946 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 53 4.625e-05 0.0002275
947 CELLULAR LIPID METABOLIC PROCESS 43 913 4.944e-05 0.0002429
948 NEGATIVE REGULATION OF IMMUNE RESPONSE 12 121 4.987e-05 0.0002448
949 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 9 69 5.149e-05 0.0002522
950 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 9 69 5.149e-05 0.0002522
951 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 16 203 5.193e-05 0.0002541
952 RESPONSE TO CADMIUM ION 7 40 5.203e-05 0.0002543
953 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 8 54 5.313e-05 0.0002594
954 PATTERN SPECIFICATION PROCESS 25 418 5.403e-05 0.0002635
955 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 6 28 5.466e-05 0.0002646
956 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 6 28 5.466e-05 0.0002646
957 POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 6 28 5.466e-05 0.0002646
958 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 6 28 5.466e-05 0.0002646
959 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 6 28 5.466e-05 0.0002646
960 REGULATION OF MULTI ORGANISM PROCESS 27 470 5.471e-05 0.0002646
961 POSITIVE REGULATION OF B CELL ACTIVATION 10 86 5.449e-05 0.0002646
962 MAMMARY GLAND DUCT MORPHOGENESIS 6 28 5.466e-05 0.0002646
963 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 162 5.609e-05 0.000271
964 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 5.659e-05 0.0002732
965 CELL PART MORPHOGENESIS 33 633 5.739e-05 0.0002767
966 I KAPPAB KINASE NF KAPPAB SIGNALING 9 70 5.78e-05 0.0002784
967 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 14 163 5.999e-05 0.0002887
968 NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 5 18 6.145e-05 0.0002921
969 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 6.083e-05 0.0002921
970 NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 7 41 6.141e-05 0.0002921
971 SMOOTH MUSCLE TISSUE DEVELOPMENT 5 18 6.145e-05 0.0002921
972 RAS PROTEIN SIGNAL TRANSDUCTION 13 143 6.1e-05 0.0002921
973 REGULATION OF B CELL MEDIATED IMMUNITY 7 41 6.141e-05 0.0002921
974 CHROMATIN ORGANIZATION 34 663 6.134e-05 0.0002921
975 REGULATION OF MYOTUBE DIFFERENTIATION 8 55 6.083e-05 0.0002921
976 PHARYNGEAL SYSTEM DEVELOPMENT 5 18 6.145e-05 0.0002921
977 PROSTATE GLAND DEVELOPMENT 7 41 6.141e-05 0.0002921
978 LYMPHOCYTE APOPTOTIC PROCESS 5 18 6.145e-05 0.0002921
979 MUSCLE CELL MIGRATION 5 18 6.145e-05 0.0002921
980 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 12 124 6.344e-05 0.0003012
981 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 6 29 6.748e-05 0.0003194
982 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 11 106 6.746e-05 0.0003194
983 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 6 29 6.748e-05 0.0003194
984 SYNAPSE ORGANIZATION 13 145 7.042e-05 0.000333
985 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 7 42 7.213e-05 0.00034
986 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 7 42 7.213e-05 0.00034
987 EPITHELIAL CELL MORPHOGENESIS 7 42 7.213e-05 0.00034
988 REGULATION OF HORMONE LEVELS 27 478 7.271e-05 0.0003424
989 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 10 89 7.323e-05 0.0003445
990 RESPONSE TO UV 12 126 7.417e-05 0.0003486
991 REGULATION OF CHROMOSOME ORGANIZATION 19 278 7.515e-05 0.0003528
992 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 13 146 7.558e-05 0.0003542
993 DNA INTEGRITY CHECKPOINT 13 146 7.558e-05 0.0003542
994 CALCIUM MEDIATED SIGNALING 10 90 8.057e-05 0.0003764
995 REGULATION OF CELL MATRIX ADHESION 10 90 8.057e-05 0.0003764
996 REGULATION OF GLIOGENESIS 10 90 8.057e-05 0.0003764
997 POSITIVE REGULATION OF PROTEIN BINDING 9 73 8.079e-05 0.0003767
998 PANCREAS DEVELOPMENT 9 73 8.079e-05 0.0003767
999 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 8.17e-05 0.0003771
1000 FIBRIL ORGANIZATION 5 19 8.17e-05 0.0003771
1001 REGULATION OF WATER LOSS VIA SKIN 5 19 8.17e-05 0.0003771
1002 MUSCLE CELL PROLIFERATION 5 19 8.17e-05 0.0003771
1003 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 5 19 8.17e-05 0.0003771
1004 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 13 147 8.107e-05 0.0003771
1005 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 5 19 8.17e-05 0.0003771
1006 REGULATION OF INTERLEUKIN 8 SECRETION 5 19 8.17e-05 0.0003771
1007 MACROPHAGE DIFFERENTIATION 5 19 8.17e-05 0.0003771
1008 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 19 8.17e-05 0.0003771
1009 SMOOTH MUSCLE CELL DIFFERENTIATION 6 30 8.259e-05 0.0003808
1010 CELL FATE DETERMINATION 7 43 8.432e-05 0.0003885
1011 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 22 354 8.622e-05 0.0003968
1012 NEGATIVE REGULATION OF HEMOPOIESIS 12 128 8.642e-05 0.000397
1013 MUSCLE CELL DEVELOPMENT 12 128 8.642e-05 0.000397
1014 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 11 109 8.71e-05 0.0003993
1015 UNSATURATED FATTY ACID METABOLIC PROCESS 11 109 8.71e-05 0.0003993
1016 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 8 58 8.972e-05 0.0004109
1017 REGULATION OF ACUTE INFLAMMATORY RESPONSE 9 74 8.998e-05 0.0004117
1018 SECRETION BY CELL 27 486 9.587e-05 0.0004382
1019 CELL DIVISION 26 460 9.754e-05 0.0004454
1020 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 7 44 9.814e-05 0.0004477
1021 RESPONSE TO INTERLEUKIN 4 6 31 0.0001003 0.0004556
1022 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 31 0.0001003 0.0004556
1023 GRANULOCYTE MIGRATION 9 75 1e-04 0.0004556
1024 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 6 31 0.0001003 0.0004556
1025 TISSUE HOMEOSTASIS 14 171 0.0001007 0.0004571
1026 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 8 59 0.0001016 0.0004602
1027 VASCULOGENESIS 8 59 0.0001016 0.0004602
1028 RESPONSE TO PROTOZOAN 5 20 0.0001067 0.0004816
1029 RESPONSE TO LIPOPROTEIN PARTICLE 5 20 0.0001067 0.0004816
1030 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 20 0.0001067 0.0004816
1031 MYELOID DENDRITIC CELL DIFFERENTIATION 5 20 0.0001067 0.0004816
1032 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 12 131 0.0001081 0.0004867
1033 REGULATION OF HORMONE SECRETION 18 262 0.0001081 0.0004867
1034 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 11 0.0001091 0.0004879
1035 CARDIAC CELL FATE COMMITMENT 4 11 0.0001091 0.0004879
1036 DETECTION OF MOLECULE OF BACTERIAL ORIGIN 4 11 0.0001091 0.0004879
1037 POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 4 11 0.0001091 0.0004879
1038 LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 4 11 0.0001091 0.0004879
1039 NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 4 11 0.0001091 0.0004879
1040 REGULATION OF NECROPTOTIC PROCESS 4 11 0.0001091 0.0004879
1041 REGULATION OF CALCIUM MEDIATED SIGNALING 9 76 0.000111 0.0004961
1042 THYMOCYTE AGGREGATION 7 45 0.0001138 0.0005055
1043 SPROUTING ANGIOGENESIS 7 45 0.0001138 0.0005055
1044 T CELL DIFFERENTIATION IN THYMUS 7 45 0.0001138 0.0005055
1045 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 7 45 0.0001138 0.0005055
1046 NEGATIVE REGULATION OF CHROMATIN MODIFICATION 7 45 0.0001138 0.0005055
1047 ENDOCHONDRAL BONE MORPHOGENESIS 7 45 0.0001138 0.0005055
1048 REGULATION OF CHROMATIN ORGANIZATION 13 152 0.000114 0.0005057
1049 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 13 152 0.000114 0.0005057
1050 OLIGODENDROCYTE DIFFERENTIATION 8 60 0.0001147 0.0005081
1051 SMALL MOLECULE METABOLIC PROCESS 69 1767 0.0001185 0.0005244
1052 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 12 133 0.0001249 0.0005521
1053 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 12 133 0.0001249 0.0005521
1054 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 8 61 0.0001291 0.0005701
1055 PROTEIN LOCALIZATION 70 1805 0.0001293 0.0005704
1056 ORGANIC ACID METABOLIC PROCESS 43 953 0.0001295 0.0005706
1057 NOTCH SIGNALING PATHWAY 11 114 0.0001307 0.0005752
1058 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 7 46 0.0001313 0.000577
1059 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 7 46 0.0001313 0.000577
1060 LYMPHOCYTE COSTIMULATION 9 78 0.000136 0.0005969
1061 CELL AGGREGATION 5 21 0.0001372 0.0006006
1062 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 5 21 0.0001372 0.0006006
1063 CARTILAGE CONDENSATION 5 21 0.0001372 0.0006006
1064 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 10 96 0.0001391 0.0006084
1065 POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 6 33 0.0001446 0.0006294
1066 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 6 33 0.0001446 0.0006294
1067 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 6 33 0.0001446 0.0006294
1068 REGULATION OF INTERLEUKIN 1 SECRETION 6 33 0.0001446 0.0006294
1069 CELLULAR MACROMOLECULE LOCALIZATION 52 1234 0.0001446 0.0006294
1070 REGULATION OF TISSUE REMODELING 8 62 0.0001451 0.0006309
1071 ERBB SIGNALING PATHWAY 9 79 0.0001501 0.0006523
1072 POSITIVE REGULATION OF GLIOGENESIS 7 47 0.000151 0.0006556
1073 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 14 178 0.0001541 0.0006684
1074 POSITIVE REGULATION OF CELLULAR EXTRAVASATION 4 12 0.0001604 0.0006909
1075 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 4 12 0.0001604 0.0006909
1076 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 12 0.0001604 0.0006909
1077 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 12 0.0001604 0.0006909
1078 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 4 12 0.0001604 0.0006909
1079 NEGATIVE REGULATION OF RECEPTOR BINDING 4 12 0.0001604 0.0006909
1080 POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 4 12 0.0001604 0.0006909
1081 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 25 448 0.0001612 0.0006939
1082 REGULATION OF CELL KILLING 8 63 0.0001626 0.0006993
1083 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 10 98 0.0001653 0.0007093
1084 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 9 80 0.0001655 0.0007093
1085 COVALENT CHROMATIN MODIFICATION 21 345 0.0001654 0.0007093
1086 CELLULAR RESPONSE TO RADIATION 12 137 0.0001656 0.0007093
1087 HORMONE MEDIATED SIGNALING PATHWAY 13 158 0.0001682 0.0007202
1088 RESPONSE TO AMINE 7 48 0.0001731 0.0007388
1089 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 7 48 0.0001731 0.0007388
1090 REGULATION OF INTERLEUKIN 2 PRODUCTION 7 48 0.0001731 0.0007388
1091 ENDOCARDIAL CUSHION MORPHOGENESIS 5 22 0.0001739 0.0007412
1092 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 5 22 0.0001739 0.0007412
1093 MAINTENANCE OF LOCATION 12 138 0.0001773 0.0007541
1094 CELL CYCLE G2 M PHASE TRANSITION 12 138 0.0001773 0.0007541
1095 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 99 0.0001798 0.0007635
1096 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 10 99 0.0001798 0.0007635
1097 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 8 64 0.0001819 0.0007714
1098 REGULATION OF CELL SHAPE 12 139 0.0001898 0.0008042
1099 SECOND MESSENGER MEDIATED SIGNALING 13 160 0.0001907 0.0008072
1100 CELL MATRIX ADHESION 11 119 0.0001916 0.0008103
1101 METENCEPHALON DEVELOPMENT 10 100 0.0001954 0.0008252
1102 MITOTIC DNA INTEGRITY CHECKPOINT 10 100 0.0001954 0.0008252
1103 ACTIN FILAMENT BUNDLE ORGANIZATION 7 49 0.0001976 0.0008322
1104 CARDIAC SEPTUM MORPHOGENESIS 7 49 0.0001976 0.0008322
1105 CARDIAC CELL DEVELOPMENT 7 49 0.0001976 0.0008322
1106 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 9 82 0.0002002 0.0008421
1107 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 15 205 0.0002017 0.0008478
1108 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 6 35 0.0002032 0.0008517
1109 POSITIVE REGULATION OF HEART CONTRACTION 6 35 0.0002032 0.0008517
1110 B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 6 35 0.0002032 0.0008517
1111 KERATINOCYTE DIFFERENTIATION 10 101 0.0002122 0.0008871
1112 REGULATION OF EXTENT OF CELL GROWTH 10 101 0.0002122 0.0008871
1113 CAMERA TYPE EYE MORPHOGENESIS 10 101 0.0002122 0.0008871
1114 ORGANOPHOSPHATE METABOLIC PROCESS 40 885 0.0002151 0.0008984
1115 PROSTATE GLAND MORPHOGENESIS 5 23 0.0002177 0.0009054
1116 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 23 0.0002177 0.0009054
1117 REGULATION OF CAMP MEDIATED SIGNALING 5 23 0.0002177 0.0009054
1118 RESPONSE TO AUDITORY STIMULUS 5 23 0.0002177 0.0009054
1119 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 5 23 0.0002177 0.0009054
1120 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 14 184 0.000218 0.0009055
1121 NIK NF KAPPAB SIGNALING 9 83 0.0002197 0.0009117
1122 GAMETE GENERATION 30 595 0.0002212 0.0009171
1123 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 4 13 0.0002271 0.0009294
1124 WHITE FAT CELL DIFFERENTIATION 4 13 0.0002271 0.0009294
1125 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 0.0002271 0.0009294
1126 REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 4 13 0.0002271 0.0009294
1127 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 4 13 0.0002271 0.0009294
1128 REGULATION OF MULTICELLULAR ORGANISM GROWTH 8 66 0.000226 0.0009294
1129 REGULATION OF REGULATORY T CELL DIFFERENTIATION 4 13 0.0002271 0.0009294
1130 RESPONSE TO PARATHYROID HORMONE 4 13 0.0002271 0.0009294
1131 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 4 13 0.0002271 0.0009294
1132 RESPONSE TO COBALT ION 4 13 0.0002271 0.0009294
1133 REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 4 13 0.0002271 0.0009294
1134 VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 4 13 0.0002271 0.0009294
1135 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 50 0.0002249 0.0009294
1136 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 13 0.0002271 0.0009294
1137 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 4 13 0.0002271 0.0009294
1138 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 10 102 0.0002301 0.0009409
1139 NEUROMUSCULAR JUNCTION DEVELOPMENT 6 36 0.0002387 0.000971
1140 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 11 122 0.0002385 0.000971
1141 CELL CYCLE PHASE TRANSITION 17 255 0.000238 0.000971
1142 NEGATIVE REGULATION OF HISTONE MODIFICATION 6 36 0.0002387 0.000971
1143 NEGATIVE REGULATION OF BLOOD CIRCULATION 6 36 0.0002387 0.000971
1144 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 6 36 0.0002387 0.000971
1145 PROTEIN OLIGOMERIZATION 24 434 0.0002479 0.001008
1146 NEURON FATE COMMITMENT 8 67 0.0002511 0.00102
1147 RESPONSE TO AMMONIUM ION 7 51 0.0002552 0.001032
1148 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 51 0.0002552 0.001032
1149 CELLULAR RESPONSE TO FATTY ACID 7 51 0.0002552 0.001032
1150 HOMOTYPIC CELL CELL ADHESION 7 51 0.0002552 0.001032
1151 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 7 51 0.0002552 0.001032
1152 PALATE DEVELOPMENT 9 85 0.0002634 0.001064
1153 NEGATIVE REGULATION OF DEFENSE RESPONSE 12 144 0.0002639 0.001065
1154 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 5 24 0.0002694 0.001085
1155 POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION 5 24 0.0002694 0.001085
1156 REGULATION OF ALPHA BETA T CELL ACTIVATION 8 68 0.0002785 0.001117
1157 RESPONSE TO NERVE GROWTH FACTOR 6 37 0.000279 0.001117
1158 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 6 37 0.000279 0.001117
1159 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 6 37 0.000279 0.001117
1160 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 37 0.000279 0.001117
1161 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 68 0.0002785 0.001117
1162 SINGLE ORGANISM CATABOLIC PROCESS 42 957 0.0002788 0.001117
1163 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 52 0.0002887 0.001151
1164 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 7 52 0.0002887 0.001151
1165 NEGATIVE REGULATION OF T CELL PROLIFERATION 7 52 0.0002887 0.001151
1166 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 7 52 0.0002887 0.001151
1167 RESPONSE TO FUNGUS 7 52 0.0002887 0.001151
1168 CELLULAR RESPONSE TO INSULIN STIMULUS 12 146 0.0002998 0.001194
1169 RESPONSE TO ACTIVITY 8 69 0.0003083 0.001227
1170 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 4 14 0.0003117 0.001231
1171 LAYER FORMATION IN CEREBRAL CORTEX 4 14 0.0003117 0.001231
1172 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 4 14 0.0003117 0.001231
1173 ATRIAL SEPTUM MORPHOGENESIS 4 14 0.0003117 0.001231
1174 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 4 14 0.0003117 0.001231
1175 RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE 4 14 0.0003117 0.001231
1176 METANEPHRIC MESENCHYME DEVELOPMENT 4 14 0.0003117 0.001231
1177 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 0.0003117 0.001231
1178 REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 14 0.0003117 0.001231
1179 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 9 87 0.000314 0.001239
1180 CARDIAC VENTRICLE DEVELOPMENT 10 106 0.000315 0.001242
1181 LYMPHOCYTE MEDIATED IMMUNITY 12 147 0.0003193 0.001257
1182 REGIONALIZATION 19 311 0.0003192 0.001257
1183 NEGATIVE REGULATION OF CELL CYCLE PROCESS 15 214 0.0003207 0.001262
1184 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 6 38 0.0003244 0.001274
1185 POSITIVE REGULATION OF ORGAN GROWTH 6 38 0.0003244 0.001274
1186 REGULATION OF BLOOD PRESSURE 13 169 0.0003262 0.00128
1187 LENS FIBER CELL DIFFERENTIATION 5 25 0.00033 0.001288
1188 MEMBRANE ASSEMBLY 5 25 0.00033 0.001288
1189 CELLULAR EXTRAVASATION 5 25 0.00033 0.001288
1190 HISTONE PHOSPHORYLATION 5 25 0.00033 0.001288
1191 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 0.00033 0.001288
1192 THYROID GLAND DEVELOPMENT 5 25 0.00033 0.001288
1193 PEPTIDYL LYSINE MODIFICATION 19 312 0.0003323 0.001296
1194 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 11 127 0.0003384 0.001319
1195 PLATELET DEGRANULATION 10 107 0.0003399 0.001323
1196 MALE SEX DIFFERENTIATION 12 148 0.0003398 0.001323
1197 OVULATION CYCLE PROCESS 9 88 0.0003422 0.00133
1198 NEGATIVE REGULATION OF CELL GROWTH 13 170 0.0003453 0.001341
1199 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 14 193 0.0003559 0.001381
1200 REGULATION OF PHOSPHATASE ACTIVITY 11 128 0.000362 0.001404
1201 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 9 89 0.0003725 0.001443
1202 REGULATION OF PHOSPHOLIPASE C ACTIVITY 6 39 0.0003754 0.001451
1203 TRABECULA MORPHOGENESIS 6 39 0.0003754 0.001451
1204 CELLULAR RESPONSE TO NUTRIENT 6 39 0.0003754 0.001451
1205 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 13 172 0.0003866 0.001493
1206 REGULATION OF MITOCHONDRION ORGANIZATION 15 218 0.0003905 0.001507
1207 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 14 195 0.000395 0.001523
1208 REGULATION OF TYPE 2 IMMUNE RESPONSE 5 26 0.0004002 0.001529
1209 POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 5 26 0.0004002 0.001529
1210 REGULATION OF MESONEPHROS DEVELOPMENT 5 26 0.0004002 0.001529
1211 REPLACEMENT OSSIFICATION 5 26 0.0004002 0.001529
1212 CELLULAR RESPONSE TO INTERLEUKIN 4 5 26 0.0004002 0.001529
1213 NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 26 0.0004002 0.001529
1214 POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 5 26 0.0004002 0.001529
1215 MESODERMAL CELL DIFFERENTIATION 5 26 0.0004002 0.001529
1216 ENDOCHONDRAL OSSIFICATION 5 26 0.0004002 0.001529
1217 CELLULAR RESPONSE TO VITAMIN 5 26 0.0004002 0.001529
1218 MYELOID DENDRITIC CELL ACTIVATION 5 26 0.0004002 0.001529
1219 NAD METABOLIC PROCESS 7 55 0.0004106 0.001566
1220 NATURAL KILLER CELL ACTIVATION 7 55 0.0004106 0.001566
1221 RESPONSE TO MURAMYL DIPEPTIDE 4 15 0.0004167 0.001578
1222 NEGATIVE REGULATION OF HISTONE ACETYLATION 4 15 0.0004167 0.001578
1223 POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 4 15 0.0004167 0.001578
1224 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 4 15 0.0004167 0.001578
1225 MUSCLE CELL FATE COMMITMENT 4 15 0.0004167 0.001578
1226 STRIATED MUSCLE CELL PROLIFERATION 4 15 0.0004167 0.001578
1227 CHRONIC INFLAMMATORY RESPONSE 4 15 0.0004167 0.001578
1228 RESPONSE TO HYDROPEROXIDE 4 15 0.0004167 0.001578
1229 POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 14 196 0.0004159 0.001578
1230 NEURON MIGRATION 10 110 0.0004247 0.001607
1231 HINDBRAIN MORPHOGENESIS 6 40 0.0004325 0.001632
1232 ACTIN FILAMENT ORGANIZATION 13 174 0.000432 0.001632
1233 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 6 40 0.0004325 0.001632
1234 LEARNING 11 131 0.0004416 0.001665
1235 HIPPOCAMPUS DEVELOPMENT 8 73 0.0004545 0.001712
1236 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 10 111 0.0004566 0.001719
1237 CARBOXYLIC ACID BIOSYNTHETIC PROCESS 17 270 0.0004615 0.001735
1238 ORGANIC ACID BIOSYNTHETIC PROCESS 17 270 0.0004615 0.001735
1239 MITOCHONDRIAL MEMBRANE ORGANIZATION 9 92 0.0004768 0.001791
1240 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 27 0.0004812 0.001796
1241 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 5 27 0.0004812 0.001796
1242 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 27 0.0004812 0.001796
1243 FATTY ACID METABOLIC PROCESS 18 296 0.0004806 0.001796
1244 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 27 0.0004812 0.001796
1245 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 5 27 0.0004812 0.001796
1246 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 5 27 0.0004812 0.001796
1247 HETEROTYPIC CELL CELL ADHESION 5 27 0.0004812 0.001796
1248 REGULATION OF LIPID STORAGE 6 41 0.0004961 0.001847
1249 TRANSLESION SYNTHESIS 6 41 0.0004961 0.001847
1250 CELLULAR RESPONSE TO ESTROGEN STIMULUS 6 41 0.0004961 0.001847
1251 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 57 0.0005126 0.001905
1252 APOPTOTIC MITOCHONDRIAL CHANGES 7 57 0.0005126 0.001905
1253 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 9 93 0.0005165 0.001918
1254 MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST 4 16 0.0005447 0.002013
1255 CARDIAC MYOFIBRIL ASSEMBLY 4 16 0.0005447 0.002013
1256 REGULATION OF MACROPHAGE CHEMOTAXIS 4 16 0.0005447 0.002013
1257 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 0.0005447 0.002013
1258 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 16 0.0005447 0.002013
1259 MONOCYTE DIFFERENTIATION 4 16 0.0005447 0.002013
1260 REGULATION OF DNA REPAIR 8 75 0.0005462 0.002016
1261 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 8 75 0.0005462 0.002016
1262 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 10 114 0.0005643 0.002079
1263 REGULATION OF EMBRYONIC DEVELOPMENT 10 114 0.0005643 0.002079
1264 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 42 0.0005668 0.002085
1265 REGULATION OF NIK NF KAPPAB SIGNALING 6 42 0.0005668 0.002085
1266 REGULATION OF DNA RECOMBINATION 7 58 0.0005707 0.002093
1267 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 5 28 0.000574 0.002093
1268 NECROTIC CELL DEATH 5 28 0.000574 0.002093
1269 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 135 0.0005701 0.002093
1270 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 5 28 0.000574 0.002093
1271 REGULATION OF NEUROBLAST PROLIFERATION 5 28 0.000574 0.002093
1272 LONG TERM MEMORY 5 28 0.000574 0.002093
1273 T CELL MEDIATED IMMUNITY 5 28 0.000574 0.002093
1274 REGULATION OF SPROUTING ANGIOGENESIS 5 28 0.000574 0.002093
1275 RESPONSE TO GONADOTROPIN 5 28 0.000574 0.002093
1276 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 5 28 0.000574 0.002093
1277 GLIAL CELL DEVELOPMENT 8 76 0.0005974 0.002177
1278 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 9 95 0.0006039 0.002199
1279 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 11 136 0.0006066 0.002207
1280 REGULATION OF DEPHOSPHORYLATION 12 158 0.0006137 0.002231
1281 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 7 59 0.0006338 0.002302
1282 HINDBRAIN DEVELOPMENT 11 137 0.0006452 0.002338
1283 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 6 43 0.000645 0.002338
1284 MORPHOGENESIS OF AN EPITHELIAL SHEET 6 43 0.000645 0.002338
1285 FEMALE SEX DIFFERENTIATION 10 116 0.0006472 0.002344
1286 STEM CELL DIVISION 5 29 0.0006795 0.002455
1287 POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING 5 29 0.0006795 0.002455
1288 REGULATION OF THE FORCE OF HEART CONTRACTION 5 29 0.0006795 0.002455
1289 MICROTUBULE BASED PROCESS 26 522 0.0006852 0.002474
1290 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 4 17 0.0006984 0.002502
1291 BRANCH ELONGATION OF AN EPITHELIUM 4 17 0.0006984 0.002502
1292 POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 17 0.0006984 0.002502
1293 HEXOSE TRANSMEMBRANE TRANSPORT 4 17 0.0006984 0.002502
1294 NEGATIVE REGULATION OF CELL AGING 4 17 0.0006984 0.002502
1295 REGULATION OF PLATELET AGGREGATION 4 17 0.0006984 0.002502
1296 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 4 17 0.0006984 0.002502
1297 POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 17 0.0006984 0.002502
1298 GLUCOSE TRANSMEMBRANE TRANSPORT 4 17 0.0006984 0.002502
1299 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 0.0006984 0.002502
1300 T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 7 60 0.0007024 0.002512
1301 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 7 60 0.0007024 0.002512
1302 TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 10 118 0.00074 0.002644
1303 MEMORY 9 98 0.0007576 0.002703
1304 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 9 98 0.0007576 0.002703
1305 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 7 61 0.0007767 0.002769
1306 MITOTIC NUCLEAR DIVISION 20 361 0.0007779 0.002772
1307 REGULATION OF PEPTIDE SECRETION 14 209 0.0007866 0.0028
1308 GLUCOSE METABOLIC PROCESS 10 119 0.0007903 0.002809
1309 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 10 119 0.0007903 0.002809
1310 SMALL MOLECULE BIOSYNTHETIC PROCESS 23 443 0.0007914 0.002811
1311 POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 5 30 0.0007989 0.002822
1312 MEMBRANE BIOGENESIS 5 30 0.0007989 0.002822
1313 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 30 0.0007989 0.002822
1314 BLASTOCYST FORMATION 5 30 0.0007989 0.002822
1315 BROWN FAT CELL DIFFERENTIATION 5 30 0.0007989 0.002822
1316 RESPONSE TO ATP 5 30 0.0007989 0.002822
1317 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 5 30 0.0007989 0.002822
1318 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 9 99 0.0008154 0.002879
1319 ENDOTHELIAL CELL DEVELOPMENT 6 45 0.0008264 0.002909
1320 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 6 45 0.0008264 0.002909
1321 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 6 45 0.0008264 0.002909
1322 SMOOTH MUSCLE CONTRACTION 6 45 0.0008264 0.002909
1323 REGULATION OF DENDRITE DEVELOPMENT 10 120 0.0008434 0.002966
1324 DEFENSE RESPONSE TO VIRUS 12 164 0.0008535 0.002999
1325 BLASTOCYST DEVELOPMENT 7 62 0.0008571 0.00301
1326 ATRIAL SEPTUM DEVELOPMENT 4 18 0.0008804 0.00308
1327 RESPONSE TO CAFFEINE 4 18 0.0008804 0.00308
1328 KIDNEY MESENCHYME DEVELOPMENT 4 18 0.0008804 0.00308
1329 POSITIVE REGULATION OF DNA RECOMBINATION 4 18 0.0008804 0.00308
1330 RESPONSE TO WATER 4 18 0.0008804 0.00308
1331 ICOSANOID BIOSYNTHETIC PROCESS 6 46 0.0009307 0.003238
1332 CARDIAC ATRIUM DEVELOPMENT 5 31 0.0009332 0.003238
1333 CEREBELLAR CORTEX DEVELOPMENT 6 46 0.0009307 0.003238
1334 REGULATION OF MICROTUBULE POLYMERIZATION 5 31 0.0009332 0.003238
1335 PEPTIDYL THREONINE MODIFICATION 6 46 0.0009307 0.003238
1336 NEURON FATE SPECIFICATION 5 31 0.0009332 0.003238
1337 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 46 0.0009307 0.003238
1338 POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 5 31 0.0009332 0.003238
1339 MISMATCH REPAIR 5 31 0.0009332 0.003238
1340 REGULATION OF PLATELET ACTIVATION 5 31 0.0009332 0.003238
1341 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 6 46 0.0009307 0.003238
1342 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 7 63 0.0009439 0.003273
1343 LOCALIZATION WITHIN MEMBRANE 10 122 0.0009584 0.00332
1344 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 12 167 0.0009999 0.003462
1345 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 7 64 0.001038 0.003584
1346 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 7 64 0.001038 0.003584
1347 REGULATION OF PROTEIN ACETYLATION 7 64 0.001038 0.003584
1348 NEURON DEATH 6 47 0.001045 0.003604
1349 POSITIVE REGULATION OF DEPHOSPHORYLATION 6 47 0.001045 0.003604
1350 RESPONSE TO FATTY ACID 8 83 0.001074 0.003703
1351 PROSTAGLANDIN BIOSYNTHETIC PROCESS 4 19 0.001093 0.003714
1352 NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 4 19 0.001093 0.003714
1353 THYMIC T CELL SELECTION 4 19 0.001093 0.003714
1354 CELLULAR RESPONSE TO FLUID SHEAR STRESS 4 19 0.001093 0.003714
1355 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.001093 0.003714
1356 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 5 32 0.001084 0.003714
1357 NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 4 19 0.001093 0.003714
1358 NEGATIVE REGULATION OF ATP METABOLIC PROCESS 4 19 0.001093 0.003714
1359 T CELL RECEPTOR SIGNALING PATHWAY 11 146 0.001092 0.003714
1360 BLOOD VESSEL REMODELING 5 32 0.001084 0.003714
1361 ENTEROENDOCRINE CELL DIFFERENTIATION 4 19 0.001093 0.003714
1362 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 4 19 0.001093 0.003714
1363 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 5 32 0.001084 0.003714
1364 ERROR PRONE TRANSLESION SYNTHESIS 4 19 0.001093 0.003714
1365 MUSCLE CELL CELLULAR HOMEOSTASIS 4 19 0.001093 0.003714
1366 NEGATIVE REGULATION OF T CELL DIFFERENTIATION 5 32 0.001084 0.003714
1367 REGULATION OF NEUTROPHIL MIGRATION 5 32 0.001084 0.003714
1368 ADIPOSE TISSUE DEVELOPMENT 5 32 0.001084 0.003714
1369 PROSTANOID BIOSYNTHETIC PROCESS 4 19 0.001093 0.003714
1370 ASTROCYTE DEVELOPMENT 4 19 0.001093 0.003714
1371 APPENDAGE DEVELOPMENT 12 169 0.001109 0.00376
1372 LIMB DEVELOPMENT 12 169 0.001109 0.00376
1373 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 14 217 0.001131 0.003833
1374 STEROID HORMONE MEDIATED SIGNALING PATHWAY 10 125 0.001155 0.00391
1375 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 8 84 0.001162 0.003933
1376 RESPONSE TO AXON INJURY 6 48 0.001169 0.003943
1377 NEGATIVE REGULATION OF COAGULATION 6 48 0.001169 0.003943
1378 REGULATION OF LIPID KINASE ACTIVITY 6 48 0.001169 0.003943
1379 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.001169 0.003943
1380 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 6 48 0.001169 0.003943
1381 MALE GAMETE GENERATION 24 486 0.001221 0.004115
1382 MICROTUBULE CYTOSKELETON ORGANIZATION 19 348 0.001237 0.004165
1383 CELLULAR RESPONSE TO UV 7 66 0.001246 0.004191
1384 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 0.001246 0.004191
1385 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 5 33 0.001251 0.004201
1386 G2 DNA DAMAGE CHECKPOINT 5 33 0.001251 0.004201
1387 CARDIAC SEPTUM DEVELOPMENT 8 85 0.001256 0.004212
1388 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 6 49 0.001305 0.004371
1389 REGULATION OF ATP METABOLIC PROCESS 6 49 0.001305 0.004371
1390 CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 4 20 0.00134 0.004454
1391 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 20 0.00134 0.004454
1392 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 20 0.00134 0.004454
1393 ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION 4 20 0.00134 0.004454
1394 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 4 20 0.00134 0.004454
1395 TELENCEPHALON GLIAL CELL MIGRATION 4 20 0.00134 0.004454
1396 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 4 20 0.00134 0.004454
1397 MEGAKARYOCYTE DIFFERENTIATION 4 20 0.00134 0.004454
1398 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 0.00134 0.004454
1399 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 0.00134 0.004454
1400 RESPONSE TO LEAD ION 4 20 0.00134 0.004454
1401 REGULATION OF HEART CONTRACTION 14 221 0.001346 0.00447
1402 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 7 67 0.001363 0.004519
1403 REGULATION OF NOTCH SIGNALING PATHWAY 7 67 0.001363 0.004519
1404 WNT SIGNALING PATHWAY 19 351 0.001366 0.004527
1405 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 34 0.001437 0.004747
1406 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 34 0.001437 0.004747
1407 ER NUCLEUS SIGNALING PATHWAY 5 34 0.001437 0.004747
1408 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 34 0.001437 0.004747
1409 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 11 151 0.001435 0.004747
1410 FACE DEVELOPMENT 6 50 0.001452 0.004792
1411 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 8 87 0.00146 0.004815
1412 NUCLEAR IMPORT 10 129 0.001466 0.004825
1413 CELL JUNCTION ASSEMBLY 10 129 0.001466 0.004825
1414 REGULATION OF CAMP METABOLIC PROCESS 10 129 0.001466 0.004825
1415 ORGAN GROWTH 7 68 0.001487 0.00489
1416 METANEPHRIC NEPHRON MORPHOGENESIS 4 21 0.001623 0.005289
1417 NECROPTOTIC PROCESS 4 21 0.001623 0.005289
1418 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 4 21 0.001623 0.005289
1419 CHONDROCYTE DEVELOPMENT 4 21 0.001623 0.005289
1420 DECIDUALIZATION 4 21 0.001623 0.005289
1421 NEURAL CREST CELL MIGRATION 6 51 0.001612 0.005289
1422 POSITIVE T CELL SELECTION 4 21 0.001623 0.005289
1423 VIRAL GENOME REPLICATION 4 21 0.001623 0.005289
1424 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 4 21 0.001623 0.005289
1425 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 0.001612 0.005289
1426 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 21 0.001623 0.005289
1427 NEGATIVE REGULATION OF PROTEIN ACETYLATION 4 21 0.001623 0.005289
1428 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 9 109 0.001615 0.005289
1429 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 5 35 0.001643 0.005328
1430 NADH METABOLIC PROCESS 5 35 0.001643 0.005328
1431 MEMBRANE PROTEIN PROTEOLYSIS 5 35 0.001643 0.005328
1432 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 5 35 0.001643 0.005328
1433 RESPONSE TO IRON ION 5 35 0.001643 0.005328
1434 RESPONSE TO MONOAMINE 5 35 0.001643 0.005328
1435 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 5 35 0.001643 0.005328
1436 ESTABLISHMENT OF LOCALIZATION IN CELL 61 1676 0.001742 0.005642
1437 POSITIVE REGULATION OF CELL DIVISION 10 132 0.001742 0.005642
1438 MUSCLE ORGAN MORPHOGENESIS 7 70 0.001762 0.005698
1439 REGULATION OF MEMBRANE PERMEABILITY 7 70 0.001762 0.005698
1440 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 11 155 0.001769 0.005717
1441 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 52 0.001784 0.005762
1442 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 9 111 0.001833 0.00591
1443 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 9 111 0.001833 0.00591
1444 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 5 36 0.00187 0.006008
1445 POSITIVE REGULATION OF AXON EXTENSION 5 36 0.00187 0.006008
1446 CELLULAR RESPONSE TO HEAT 5 36 0.00187 0.006008
1447 TOXIN TRANSPORT 5 36 0.00187 0.006008
1448 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 5 36 0.00187 0.006008
1449 CELL FATE SPECIFICATION 7 71 0.001914 0.006146
1450 CELLULAR RESPONSE TO VIRUS 4 22 0.001945 0.006208
1451 NEGATIVE REGULATION OF MUSCLE CONTRACTION 4 22 0.001945 0.006208
1452 BONE CELL DEVELOPMENT 4 22 0.001945 0.006208
1453 SEX DETERMINATION 4 22 0.001945 0.006208
1454 POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION 4 22 0.001945 0.006208
1455 REGULATION OF CELLULAR EXTRAVASATION 4 22 0.001945 0.006208
1456 REGULATION OF T CELL CYTOKINE PRODUCTION 4 22 0.001945 0.006208
1457 EMBRYONIC PLACENTA MORPHOGENESIS 4 22 0.001945 0.006208
1458 HISTONE H3 DEACETYLATION 4 22 0.001945 0.006208
1459 CELLULAR RESPONSE TO LIGHT STIMULUS 8 91 0.001949 0.00621
1460 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 10 134 0.001949 0.00621
1461 OXIDATION REDUCTION PROCESS 37 898 0.001959 0.006234
1462 HEXOSE METABOLIC PROCESS 11 157 0.001959 0.006234
1463 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 6 53 0.001971 0.006263
1464 NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 6 53 0.001971 0.006263
1465 FC RECEPTOR SIGNALING PATHWAY 13 206 0.00204 0.00648
1466 CELL GROWTH 10 135 0.002059 0.006535
1467 PHOSPHOLIPID METABOLIC PROCESS 19 364 0.002066 0.006554
1468 URETER DEVELOPMENT 3 11 0.002181 0.006807
1469 REGULATION OF CHOLESTEROL HOMEOSTASIS 3 11 0.002181 0.006807
1470 NEGATIVE REGULATION OF SODIUM ION TRANSPORT 3 11 0.002181 0.006807
1471 NEGATIVE REGULATION OF GLYCOLYTIC PROCESS 3 11 0.002181 0.006807
1472 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 3 11 0.002181 0.006807
1473 POSTREPLICATION REPAIR 6 54 0.002171 0.006807
1474 VENTRAL SPINAL CORD INTERNEURON SPECIFICATION 3 11 0.002181 0.006807
1475 RESPONSE TO GRAVITY 3 11 0.002181 0.006807
1476 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 3 11 0.002181 0.006807
1477 REGULATION OF CHRONIC INFLAMMATORY RESPONSE 3 11 0.002181 0.006807
1478 SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 3 11 0.002181 0.006807
1479 MONOSACCHARIDE TRANSPORT 6 54 0.002171 0.006807
1480 REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 3 11 0.002181 0.006807
1481 BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 3 11 0.002181 0.006807
1482 CYCLOOXYGENASE PATHWAY 3 11 0.002181 0.006807
1483 NEGATIVE REGULATION OF CELLULAR SENESCENCE 3 11 0.002181 0.006807
1484 NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS 3 11 0.002181 0.006807
1485 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 6 54 0.002171 0.006807
1486 POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 3 11 0.002181 0.006807
1487 NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS 3 11 0.002181 0.006807
1488 REGULATION OF INTERFERON GAMMA SECRETION 3 11 0.002181 0.006807
1489 CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 3 11 0.002181 0.006807
1490 VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 3 11 0.002181 0.006807
1491 NEGATIVE REGULATION OF NECROTIC CELL DEATH 3 11 0.002181 0.006807
1492 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 14 233 0.002205 0.006867
1493 MUSCLE CONTRACTION 14 233 0.002205 0.006867
1494 REGULATION OF ENDOTHELIAL CELL MIGRATION 9 114 0.002203 0.006867
1495 EMBRYONIC HEART TUBE DEVELOPMENT 7 73 0.002247 0.00699
1496 G1 DNA DAMAGE CHECKPOINT 7 73 0.002247 0.00699
1497 DNA REPAIR 23 480 0.002249 0.006992
1498 ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 4 23 0.002309 0.007133
1499 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 4 23 0.002309 0.007133
1500 REGULATION OF OSTEOBLAST PROLIFERATION 4 23 0.002309 0.007133
1501 EPIBOLY 4 23 0.002309 0.007133
1502 ACTIN FILAMENT POLYMERIZATION 4 23 0.002309 0.007133
1503 TRABECULA FORMATION 4 23 0.002309 0.007133
1504 STRIATED MUSCLE ADAPTATION 4 23 0.002309 0.007133
1505 POSITIVE REGULATION OF STEROID METABOLIC PROCESS 4 23 0.002309 0.007133
1506 REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 23 0.002309 0.007133
1507 REGULATION OF DOUBLE STRAND BREAK REPAIR 5 38 0.00239 0.00736
1508 SPINDLE LOCALIZATION 5 38 0.00239 0.00736
1509 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 5 38 0.00239 0.00736
1510 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 38 0.00239 0.00736
1511 CYTOKINE SECRETION 5 38 0.00239 0.00736
1512 REGULATION OF DNA BIOSYNTHETIC PROCESS 8 94 0.002393 0.007363
1513 REGULATION OF DENDRITE MORPHOGENESIS 7 74 0.00243 0.007474
1514 PROTEIN SECRETION 9 116 0.002481 0.007624
1515 NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 10 139 0.002551 0.007836
1516 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 95 0.002557 0.007844
1517 CANONICAL WNT SIGNALING PATHWAY 8 95 0.002557 0.007844
1518 REGULATION OF NUCLEAR DIVISION 11 163 0.002627 0.00805
1519 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 9 117 0.00263 0.00805
1520 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 9 117 0.00263 0.00805
1521 ATP GENERATION FROM ADP 5 39 0.002686 0.008196
1522 ERBB2 SIGNALING PATHWAY 5 39 0.002686 0.008196
1523 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 39 0.002686 0.008196
1524 COCHLEA DEVELOPMENT 5 39 0.002686 0.008196
1525 SPLEEN DEVELOPMENT 5 39 0.002686 0.008196
1526 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 4 24 0.002717 0.008256
1527 RESPONSE TO STEROL 4 24 0.002717 0.008256
1528 SPINAL CORD PATTERNING 4 24 0.002717 0.008256
1529 REGULATION OF ODONTOGENESIS 4 24 0.002717 0.008256
1530 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 4 24 0.002717 0.008256
1531 ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 4 24 0.002717 0.008256
1532 ICOSANOID METABOLIC PROCESS 8 96 0.00273 0.008287
1533 FATTY ACID DERIVATIVE METABOLIC PROCESS 8 96 0.00273 0.008287
1534 SINGLE ORGANISM BIOSYNTHETIC PROCESS 50 1340 0.002778 0.008427
1535 NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 14 239 0.002781 0.008429
1536 TOLERANCE INDUCTION 3 12 0.002855 0.008565
1537 REGULATION OF TIMING OF CELL DIFFERENTIATION 3 12 0.002855 0.008565
1538 NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 3 12 0.002855 0.008565
1539 CELLULAR RESPONSE TO ATP 3 12 0.002855 0.008565
1540 NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 3 12 0.002855 0.008565
1541 REGULATION OF CHEMOKINE SECRETION 3 12 0.002855 0.008565
1542 POST EMBRYONIC MORPHOGENESIS 3 12 0.002855 0.008565
1543 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 3 12 0.002855 0.008565
1544 PERK MEDIATED UNFOLDED PROTEIN RESPONSE 3 12 0.002855 0.008565
1545 I KAPPAB PHOSPHORYLATION 3 12 0.002855 0.008565
1546 REGULATION OF DEVELOPMENT HETEROCHRONIC 3 12 0.002855 0.008565
1547 CELL ADHESION MEDIATED BY INTEGRIN 3 12 0.002855 0.008565
1548 RENAL ABSORPTION 3 12 0.002855 0.008565
1549 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 3 12 0.002855 0.008565
1550 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 0.002855 0.008565
1551 REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 3 12 0.002855 0.008565
1552 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 8 97 0.002913 0.008732
1553 PROTEIN CATABOLIC PROCESS 26 579 0.002923 0.008759
1554 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 5 40 0.003008 0.00899
1555 POSITIVE REGULATION OF CELL MATRIX ADHESION 5 40 0.003008 0.00899
1556 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 5 40 0.003008 0.00899
1557 REGULATION OF FILOPODIUM ASSEMBLY 5 40 0.003008 0.00899
1558 REGULATION OF SODIUM ION TRANSPORT 7 77 0.003047 0.009089
1559 ACTOMYOSIN STRUCTURE ORGANIZATION 7 77 0.003047 0.009089
1560 CELLULAR TRANSITION METAL ION HOMEOSTASIS 7 77 0.003047 0.009089
1561 NEGATIVE REGULATION OF WOUND HEALING 6 58 0.00313 0.009331
1562 CELLULAR RESPONSE TO EPIDERMAL GROWTH FACTOR STIMULUS 4 25 0.003171 0.009399
1563 DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION 4 25 0.003171 0.009399
1564 POSITIVE REGULATION OF COAGULATION 4 25 0.003171 0.009399
1565 POSITIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY 4 25 0.003171 0.009399
1566 DOPAMINE METABOLIC PROCESS 4 25 0.003171 0.009399
1567 CARBOHYDRATE TRANSMEMBRANE TRANSPORT 4 25 0.003171 0.009399
1568 POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 4 25 0.003171 0.009399
1569 EPITHELIAL CELL APOPTOTIC PROCESS 4 25 0.003171 0.009399
1570 REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 4 25 0.003171 0.009399
1571 REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 7 78 0.003278 0.009708
1572 DNA DEPENDENT DNA REPLICATION 8 99 0.003305 0.009784
1573 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 16 297 0.003323 0.009829
1574 CELL SUBSTRATE JUNCTION ASSEMBLY 5 41 0.003357 0.009912
1575 MONOCYTE CHEMOTAXIS 5 41 0.003357 0.009912
1576 RECEPTOR CLUSTERING 5 41 0.003357 0.009912
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 127 1476 1.183e-36 1.099e-33
2 MACROMOLECULAR COMPLEX BINDING 113 1399 7.182e-30 3.336e-27
3 ENZYME BINDING 126 1737 5.294e-29 1.639e-26
4 IDENTICAL PROTEIN BINDING 99 1209 1.807e-26 4.197e-24
5 TRANSCRIPTION FACTOR BINDING 62 524 8.762e-25 1.628e-22
6 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 62 629 1.343e-20 2.079e-18
7 REGULATORY REGION NUCLEIC ACID BINDING 71 818 2.383e-20 3.162e-18
8 PROTEIN KINASE ACTIVITY 57 640 5.844e-17 6.786e-15
9 KINASE ACTIVITY 66 842 1.089e-16 1.124e-14
10 DOUBLE STRANDED DNA BINDING 62 764 1.986e-16 1.845e-14
11 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 53 588 4.768e-16 4.027e-14
12 CYTOKINE RECEPTOR BINDING 35 271 1.4e-15 1.084e-13
13 KINASE BINDING 53 606 1.689e-15 1.207e-13
14 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 37 315 4.609e-15 3.058e-13
15 PROTEIN COMPLEX BINDING 67 935 5.333e-15 3.303e-13
16 SEQUENCE SPECIFIC DNA BINDING 71 1037 7.499e-15 4.354e-13
17 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 69 992 8.707e-15 4.758e-13
18 CHROMATIN BINDING 43 435 1.33e-14 6.862e-13
19 PROTEIN DIMERIZATION ACTIVITY 75 1149 1.442e-14 7.05e-13
20 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 37 328 1.672e-14 7.768e-13
21 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 76 1199 4.337e-14 1.919e-12
22 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 20 90 5.85e-14 2.47e-12
23 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 29 226 4.748e-13 1.918e-11
24 PROTEIN HOMODIMERIZATION ACTIVITY 54 722 5.581e-13 2.16e-11
25 CORE PROMOTER BINDING 23 152 4.081e-12 1.517e-10
26 CYTOKINE ACTIVITY 27 219 7.971e-12 2.848e-10
27 GROWTH FACTOR RECEPTOR BINDING 20 129 6.619e-11 2.278e-09
28 SIGNAL TRANSDUCER ACTIVITY 86 1731 3.907e-10 1.296e-08
29 GLYCOPROTEIN BINDING 17 101 4.824e-10 1.545e-08
30 PROTEIN SERINE THREONINE KINASE ACTIVITY 36 445 6.074e-10 1.881e-08
31 MOLECULAR FUNCTION REGULATOR 72 1353 7.334e-10 2.198e-08
32 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 19 133 8.372e-10 2.43e-08
33 HISTONE DEACETYLASE BINDING 17 105 9.023e-10 2.54e-08
34 CELL ADHESION MOLECULE BINDING 22 186 1.557e-09 4.254e-08
35 GLYCOSAMINOGLYCAN BINDING 23 205 1.874e-09 4.975e-08
36 PROTEIN HETERODIMERIZATION ACTIVITY 36 468 2.362e-09 6.094e-08
37 PROTEIN TYROSINE KINASE ACTIVITY 21 176 3.132e-09 7.863e-08
38 GROWTH FACTOR ACTIVITY 20 160 3.297e-09 8.061e-08
39 GROWTH FACTOR BINDING 17 123 1.086e-08 2.586e-07
40 PEPTIDASE REGULATOR ACTIVITY 22 214 2.129e-08 4.944e-07
41 RECEPTOR ACTIVITY 78 1649 2.548e-08 5.773e-07
42 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 15 101 2.966e-08 6.561e-07
43 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 15 104 4.442e-08 9.597e-07
44 PROTEIN DOMAIN SPECIFIC BINDING 40 624 5.144e-08 1.086e-06
45 CYTOKINE BINDING 14 92 6.259e-08 1.292e-06
46 ENZYME REGULATOR ACTIVITY 52 959 1.192e-07 2.408e-06
47 VIRUS RECEPTOR ACTIVITY 12 70 1.427e-07 2.763e-06
48 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 70 1.427e-07 2.763e-06
49 ADENYL NUCLEOTIDE BINDING 71 1514 1.66e-07 3.147e-06
50 SMAD BINDING 12 72 1.97e-07 3.661e-06
51 PEPTIDASE ACTIVATOR ACTIVITY 9 38 2.935e-07 5.346e-06
52 PROTEASE BINDING 14 104 3.007e-07 5.373e-06
53 INTEGRIN BINDING 14 105 3.392e-07 5.946e-06
54 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 13 92 4.499e-07 7.74e-06
55 CORE PROMOTER PROXIMAL REGION DNA BINDING 27 371 7.328e-07 1.238e-05
56 LOW DENSITY LIPOPROTEIN PARTICLE BINDING 6 15 9.563e-07 1.586e-05
57 HORMONE RECEPTOR BINDING 17 168 1.071e-06 1.746e-05
58 RECEPTOR SIGNALING PROTEIN ACTIVITY 17 172 1.488e-06 2.383e-05
59 TRANSCRIPTION COACTIVATOR ACTIVITY 23 296 1.613e-06 2.54e-05
60 HEPARIN BINDING 16 157 2.017e-06 3.123e-05
61 G PROTEIN COUPLED RECEPTOR BINDING 21 259 2.334e-06 3.554e-05
62 SERINE HYDROLASE ACTIVITY 20 242 3.03e-06 4.356e-05
63 SIGNALING RECEPTOR ACTIVITY 63 1393 2.998e-06 4.356e-05
64 PHOSPHATASE BINDING 16 162 3.048e-06 4.356e-05
65 TRANSCRIPTION COREPRESSOR ACTIVITY 19 221 2.994e-06 4.356e-05
66 RIBONUCLEOTIDE BINDING 78 1860 3.163e-06 4.452e-05
67 PLATELET DERIVED GROWTH FACTOR BINDING 5 11 3.829e-06 5.309e-05
68 HISTONE ACETYLTRANSFERASE BINDING 7 28 4.279e-06 5.846e-05
69 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 5.142e-06 6.923e-05
70 CALCIUM ION BINDING 38 697 5.745e-06 7.517e-05
71 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 9 53 5.728e-06 7.517e-05
72 SULFUR COMPOUND BINDING 19 234 6.892e-06 8.893e-05
73 TRANSITION METAL ION BINDING 62 1400 7.045e-06 8.966e-05
74 PROTEIN PHOSPHATASE BINDING 13 120 9.373e-06 0.0001177
75 ACTIVATING TRANSCRIPTION FACTOR BINDING 9 57 1.065e-05 0.0001301
76 REPRESSING TRANSCRIPTION FACTOR BINDING 9 57 1.065e-05 0.0001301
77 LIPOPROTEIN PARTICLE RECEPTOR BINDING 6 22 1.229e-05 0.0001464
78 FERROUS IRON BINDING 6 22 1.229e-05 0.0001464
79 HEAT SHOCK PROTEIN BINDING 11 89 1.295e-05 0.0001523
80 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 15 168 2.09e-05 0.0002427
81 PROTEIN LIPID COMPLEX BINDING 6 24 2.125e-05 0.0002437
82 ICOSANOID RECEPTOR ACTIVITY 5 15 2.291e-05 0.0002596
83 RETINOID X RECEPTOR BINDING 5 17 4.531e-05 0.0005071
84 BHLH TRANSCRIPTION FACTOR BINDING 6 28 5.466e-05 0.0006045
85 KINASE REGULATOR ACTIVITY 15 186 6.822e-05 0.0007456
86 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 7 42 7.213e-05 0.0007791
87 CYTOKINE RECEPTOR ACTIVITY 10 89 7.323e-05 0.0007819
88 CHEMOKINE RECEPTOR BINDING 8 57 7.905e-05 0.0008345
89 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 8.259e-05 0.000862
90 ENHANCER BINDING 10 93 0.0001065 0.001099
91 RECEPTOR REGULATOR ACTIVITY 7 45 0.0001138 0.001161
92 RECEPTOR ACTIVATOR ACTIVITY 6 32 0.0001208 0.00122
93 KINASE ACTIVATOR ACTIVITY 8 62 0.0001451 0.001436
94 PEPTIDASE INHIBITOR ACTIVITY 14 177 0.0001453 0.001436
95 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 7 47 0.000151 0.001477
96 PEPTIDOGLYCAN BINDING 4 12 0.0001604 0.001544
97 ENDOPEPTIDASE ACTIVITY 25 448 0.0001612 0.001544
98 AMIDE BINDING 18 272 0.0001727 0.001608
99 CHEMOKINE ACTIVITY 7 48 0.0001731 0.001608
100 CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 34 0.0001719 0.001608
101 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 64 0.0001819 0.001659
102 STEROID HORMONE RECEPTOR BINDING 9 81 0.0001822 0.001659
103 STRUCTURAL CONSTITUENT OF CYTOSKELETON 10 100 0.0001954 0.001763
104 COLLAGEN BINDING 8 65 0.0002029 0.001796
105 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 8 65 0.0002029 0.001796
106 CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 5 23 0.0002177 0.001908
107 ENZYME INHIBITOR ACTIVITY 22 378 0.0002199 0.001909
108 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 4 13 0.0002271 0.001953
109 PROTEIN C TERMINUS BINDING 14 186 0.0002438 0.002078
110 EPHRIN RECEPTOR BINDING 5 24 0.0002694 0.002276
111 LONG CHAIN FATTY ACID BINDING 4 14 0.0003117 0.002609
112 ENZYME ACTIVATOR ACTIVITY 25 471 0.0003437 0.002851
113 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 6 39 0.0003754 0.003087
114 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 26 0.0004002 0.003262
115 ESTROGEN RECEPTOR BINDING 6 40 0.0004325 0.003494
116 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 9 91 0.0004396 0.003521
117 METALLOENDOPEPTIDASE ACTIVITY 10 113 0.0005263 0.004179
118 TRANSFORMING GROWTH FACTOR BETA BINDING 4 16 0.0005447 0.004182
119 RECEPTOR AGONIST ACTIVITY 4 16 0.0005447 0.004182
120 LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 4 16 0.0005447 0.004182
121 CXCR CHEMOKINE RECEPTOR BINDING 4 16 0.0005447 0.004182
122 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 0.0005974 0.004549
123 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 228 0.0006244 0.004716
124 SH3 DOMAIN BINDING 10 116 0.0006472 0.004849
125 LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING 4 17 0.0006984 0.005109
126 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 4 17 0.0006984 0.005109
127 SIGNALING PATTERN RECOGNITION RECEPTOR ACTIVITY 4 17 0.0006984 0.005109
128 HSP70 PROTEIN BINDING 5 30 0.0007989 0.005709
129 MHC PROTEIN BINDING 5 30 0.0007989 0.005709
130 TUMOR NECROSIS FACTOR RECEPTOR BINDING 5 30 0.0007989 0.005709
131 RETINOIC ACID RECEPTOR BINDING 6 45 0.0008264 0.005861
132 METALLOPEPTIDASE ACTIVITY 13 188 0.0008943 0.006294
133 FATTY ACID BINDING 5 31 0.0009332 0.00647
134 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 6 46 0.0009307 0.00647
135 UBIQUITIN LIKE PROTEIN LIGASE BINDING 16 264 0.001008 0.006933
136 CYCLIN BINDING 4 19 0.001093 0.007255
137 NITRIC OXIDE SYNTHASE BINDING 4 19 0.001093 0.007255
138 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 4 19 0.001093 0.007255
139 PROTEIN N TERMINUS BINDING 9 103 0.001083 0.007255
140 HISTONE KINASE ACTIVITY 4 19 0.001093 0.007255
141 MONOCARBOXYLIC ACID BINDING 7 65 0.001138 0.007499
142 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 6 48 0.001169 0.00765
143 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 9 105 0.001242 0.008068
144 PEPTIDASE ACTIVITY 30 663 0.001283 0.008278
145 MONOSACCHARIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 4 20 0.00134 0.008586
146 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 8 86 0.001355 0.008621
147 E BOX BINDING 5 34 0.001437 0.009084
NumGOOverlapSizeP ValueAdj. P Value
1 CELL SURFACE 83 757 9.253e-31 5.404e-28
2 EXTRACELLULAR SPACE 107 1376 7.907e-27 2.309e-24
3 SIDE OF MEMBRANE 51 428 1.206e-20 2.348e-18
4 MEMBRANE MICRODOMAIN 42 288 1.761e-20 2.571e-18
5 EXTRACELLULAR MATRIX 47 426 9.677e-18 1.13e-15
6 INTRINSIC COMPONENT OF PLASMA MEMBRANE 101 1649 1.162e-17 1.131e-15
7 EXTERNAL SIDE OF PLASMA MEMBRANE 35 238 2.268e-17 1.892e-15
8 MEMBRANE REGION 74 1134 2.253e-14 1.645e-12
9 RECEPTOR COMPLEX 35 327 4.168e-13 2.705e-11
10 PROTEINACEOUS EXTRACELLULAR MATRIX 35 356 4.909e-12 2.867e-10
11 ANCHORING JUNCTION 41 489 1.211e-11 6.428e-10
12 CELL SUBSTRATE JUNCTION 36 398 2.698e-11 1.313e-09
13 PLASMA MEMBRANE RECEPTOR COMPLEX 23 175 7.813e-11 3.51e-09
14 TRANSCRIPTION FACTOR COMPLEX 29 298 4.39e-10 1.831e-08
15 PERINUCLEAR REGION OF CYTOPLASM 44 642 1.416e-09 5.512e-08
16 INTRACELLULAR VESICLE 66 1259 7.473e-09 2.727e-07
17 VESICLE LUMEN 16 106 8.07e-09 2.772e-07
18 NUCLEAR CHROMOSOME 37 523 1.329e-08 4.312e-07
19 CHROMOSOME 51 880 1.944e-08 5.976e-07
20 ENDOCYTIC VESICLE 24 256 2.945e-08 8.599e-07
21 CELL JUNCTION 60 1151 4.75e-08 1.321e-06
22 CELL LEADING EDGE 28 350 6.485e-08 1.722e-06
23 CHROMATIN 32 441 7.31e-08 1.856e-06
24 MEDIATOR COMPLEX 9 34 1.032e-07 2.511e-06
25 VACUOLE 60 1180 1.134e-07 2.648e-06
26 CYTOPLASMIC VESICLE PART 38 601 1.594e-07 3.581e-06
27 PLASMA MEMBRANE RAFT 13 86 2.009e-07 4.345e-06
28 ENDOSOME 45 793 2.542e-07 5.301e-06
29 PLASMA MEMBRANE REGION 50 929 2.658e-07 5.352e-06
30 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 8 30 5.048e-07 9.827e-06
31 PLASMA MEMBRANE PROTEIN COMPLEX 33 510 6.373e-07 1.201e-05
32 ENDOPLASMIC RETICULUM LUMEN 19 201 7.197e-07 1.313e-05
33 NUCLEAR CHROMATIN 23 291 1.204e-06 2.132e-05
34 CYTOPLASMIC SIDE OF MEMBRANE 17 170 1.264e-06 2.171e-05
35 CELL PROJECTION 77 1786 1.311e-06 2.187e-05
36 EXTRACELLULAR MATRIX COMPONENT 14 125 2.877e-06 4.666e-05
37 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 14 127 3.476e-06 5.486e-05
38 EXTRINSIC COMPONENT OF MEMBRANE 20 252 5.595e-06 8.599e-05
39 ENDOCYTIC VESICLE MEMBRANE 15 152 6.246e-06 9.352e-05
40 BANDED COLLAGEN FIBRIL 5 12 6.43e-06 9.387e-05
41 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 12 101 7.957e-06 0.0001133
42 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 19 237 8.277e-06 0.0001151
43 COLLAGEN TRIMER 11 88 1.161e-05 0.0001576
44 PLATELET ALPHA GRANULE 10 75 1.628e-05 0.0002161
45 CELL BODY 29 494 1.96e-05 0.0002543
46 SECRETORY GRANULE 23 352 2.762e-05 0.0003432
47 LAMELLIPODIUM 15 172 2.759e-05 0.0003432
48 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 13 136 3.61e-05 0.0004392
49 APICAL PART OF CELL 23 361 4.09e-05 0.0004847
50 SOMATODENDRITIC COMPARTMENT 34 650 4.15e-05 0.0004847
51 NUCLEOPLASM PART 36 708 4.448e-05 0.0005093
52 SECRETORY GRANULE LUMEN 10 85 4.923e-05 0.0005425
53 NEURON PROJECTION 44 942 4.894e-05 0.0005425
54 NEUROMUSCULAR JUNCTION 8 54 5.313e-05 0.0005746
55 PLATELET ALPHA GRANULE LUMEN 8 55 6.083e-05 0.0006409
56 PHAGOCYTIC CUP 5 18 6.145e-05 0.0006409
57 EARLY ENDOSOME 20 301 7.239e-05 0.0007417
58 NEURON PART 54 1265 7.675e-05 0.0007728
59 OUTER MEMBRANE 15 190 8.682e-05 0.0008594
60 SPINDLE MICROTUBULE 8 58 8.972e-05 0.0008733
61 VESICLE MEMBRANE 28 512 9.347e-05 0.0008948
62 ENDOPLASMIC RETICULUM 65 1631 0.0001067 0.001005
63 ACTOMYOSIN 8 62 0.0001451 0.001345
64 RUFFLE 13 156 0.0001481 0.001352
65 COMPLEX OF COLLAGEN TRIMERS 5 23 0.0002177 0.001956
66 SECRETORY VESICLE 25 461 0.0002493 0.002206
67 MEMBRANE PROTEIN COMPLEX 44 1020 0.0002897 0.002525
68 LYTIC VACUOLE 27 526 0.0003421 0.002938
69 AXON 23 418 0.000356 0.003013
70 GOLGI APPARATUS 57 1445 0.0003778 0.003152
71 TRANSFERASE COMPLEX 33 703 0.0003963 0.003259
72 PROTEIN KINASE COMPLEX 9 90 0.0004049 0.003272
73 APICAL PLASMA MEMBRANE 18 292 0.000409 0.003272
74 CATALYTIC COMPLEX 44 1038 0.0004195 0.003311
75 TRANSCRIPTIONAL REPRESSOR COMPLEX 8 74 0.0004986 0.003883
76 ACTIN FILAMENT BUNDLE 7 57 0.0005126 0.003917
77 BASEMENT MEMBRANE 9 93 0.0005165 0.003917
78 VACUOLAR LUMEN 10 115 0.0006046 0.004527
79 SYNAPSE 34 754 0.0006619 0.004893
80 CYTOSKELETON 71 1967 0.0009005 0.006574

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 TNF_signaling_pathway_hsa04668 30 108 2.371e-23 1.233e-21
2 PI3K_Akt_signaling_pathway_hsa04151 49 352 7.948e-23 2.066e-21
3 Cytokine_cytokine_receptor_interaction_hsa04060 39 270 6.045e-19 1.048e-17
4 FoxO_signaling_pathway_hsa04068 28 132 1.898e-18 2.468e-17
5 Apoptosis_hsa04210 28 138 6.633e-18 6.898e-17
6 MAPK_signaling_pathway_hsa04010 39 295 1.394e-17 1.208e-16
7 Focal_adhesion_hsa04510 30 199 2.309e-15 1.715e-14
8 Cellular_senescence_hsa04218 25 160 2.224e-13 1.446e-12
9 Rap1_signaling_pathway_hsa04015 26 206 1.143e-11 6.603e-11
10 Cell_cycle_hsa04110 20 124 3.152e-11 1.639e-10
11 Jak_STAT_signaling_pathway_hsa04630 22 162 1.06e-10 5.01e-10
12 Phagosome_hsa04145 21 152 2.039e-10 8.834e-10
13 Hippo_signaling_pathway_hsa04390 21 154 2.613e-10 1.045e-09
14 NF_kappa_B_signaling_pathway_hsa04064 16 95 1.553e-09 5.77e-09
15 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 19 139 1.793e-09 6.215e-09
16 Regulation_of_actin_cytoskeleton_hsa04810 22 208 1.264e-08 4.109e-08
17 TGF_beta_signaling_pathway_hsa04350 14 84 1.891e-08 5.785e-08
18 Ras_signaling_pathway_hsa04014 23 232 2.021e-08 5.838e-08
19 HIF_1_signaling_pathway_hsa04066 15 100 2.584e-08 7.072e-08
20 Adherens_junction_hsa04520 12 72 1.97e-07 5.123e-07
21 Necroptosis_hsa04217 17 164 7.629e-07 1.889e-06
22 ECM_receptor_interaction_hsa04512 12 82 8.481e-07 1.967e-06
23 p53_signaling_pathway_hsa04115 11 68 8.699e-07 1.967e-06
24 mTOR_signaling_pathway_hsa04150 14 151 2.573e-05 5.575e-05
25 cAMP_signaling_pathway_hsa04024 16 198 3.843e-05 7.509e-05
26 Sphingolipid_signaling_pathway_hsa04071 12 118 3.888e-05 7.509e-05
27 Apelin_signaling_pathway_hsa04371 13 137 3.899e-05 7.509e-05
28 AMPK_signaling_pathway_hsa04152 12 121 4.987e-05 9.261e-05
29 Calcium_signaling_pathway_hsa04020 15 182 5.32e-05 9.54e-05
30 Gap_junction_hsa04540 10 88 6.645e-05 0.0001152
31 Autophagy_animal_hsa04140 12 128 8.642e-05 0.000145
32 Apoptosis_multiple_species_hsa04215 6 33 0.0001446 0.000235
33 ErbB_signaling_pathway_hsa04012 9 85 0.0002634 0.000415
34 VEGF_signaling_pathway_hsa04370 7 59 0.0006338 0.0009694
35 cGMP_PKG_signaling_pathway_hsa04022 12 163 0.0008088 0.001202
36 Cell_adhesion_molecules_.CAMs._hsa04514 11 145 0.001033 0.001492
37 Oocyte_meiosis_hsa04114 10 124 0.001086 0.001495
38 Wnt_signaling_pathway_hsa04310 11 146 0.001092 0.001495
39 Phospholipase_D_signaling_pathway_hsa04072 10 146 0.003637 0.004849
40 Notch_signaling_pathway_hsa04330 5 48 0.006656 0.008653
41 Endocytosis_hsa04144 12 244 0.0197 0.02498
42 Neuroactive_ligand_receptor_interaction_hsa04080 13 278 0.02259 0.0276
43 Mitophagy_animal_hsa04137 5 65 0.02282 0.0276
44 Tight_junction_hsa04530 9 170 0.02682 0.0317
45 Hippo_signaling_pathway_multiple_species_hsa04392 3 29 0.03472 0.04012
46 Ferroptosis_hsa04216 3 40 0.07704 0.08709
47 Hedgehog_signaling_pathway_hsa04340 3 47 0.1117 0.1236
48 Lysosome_hsa04142 5 123 0.1928 0.2089
49 Peroxisome_hsa04146 2 83 0.6158 0.6535

Quest ID: 8b1f7e7680a22a3e9208a946bac0d079